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Neural stem cells (NSCs) are undifferentiated cells of the central 
nervous system (CNS) which can self-renew and are multipotent. Studying 
NSCs is crucial for understanding neurodevelopment and developing 
treatment for neurological diseases. Neurospheres have been widely used to 
culture and study NSCs and neural progenitors (NPs) for over 20 years. 
However, we still do not have a clear understanding of neurospheres and a 
number of specific questions still persist. First, the exact cell types present 
within neurospheres are unknown. Second, the identity of a neurosphere-
forming cell (NFC) and NSC in vitro remains elusive. Third, due to the lack of 
specific NSC markers, it remains difficult to distinguish NSCs from NPs in 
vitro and the genes and signalling pathways regulating behavior of these cell 
types are not fully understood.  
To identify cell types within neurospheres, I performed single-cell 
mRNA profiling of 48 genes in neurosphere cells. I identified three distinct 
cell populations within neurospheres which are distinguished by their 
expression level of Bmi1, Hes5, Myc and Klf12. The mRNA profiles suggest 
that these clusters follow a developmental timeline of early, intermediate and 
late NPs, similar to the clusters found in vivo from mouse brain.  
I then enriched for NFCs using morphological criteria of cell size and 
granularity to identify an NFC cluster. Clustering of cells both with increased 
and decreased cell size and granularity identified an NFC cluster. The mRNA 
profile indicated that NFCs are highly proliferative. Strikingly, the mRNA 
profile of NFCs resembled that of early NPs, suggesting that early NPs are the 
cell population that gives rise to neurospheres.  
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To identify an NSC cluster, I performed single-cell mRNA profiling of 
48 genes in LeX+ve CD93+ve and LeX+ve CD93-ve cells , two populations 
enriched for NSCs. Clustering of LeX+ve CD93+ve and LeX+ve CD93-ve cells 
identified an NSC cluster, a bi/unipotent cluster and a non-NFC cluster. The 
mRNA profile of NSCs reaffirms that these cells self-renew, are highly 
proliferative and are undifferentiated. Importantly, the mRNA profiles provide 
a clear distinction, for the first time, between NSCs and bi/unipotent NPs in 
neurospheres. Lastly, I profiled the expression level of 48 genes in NSCs 
within the LeX+ve CD93+ve population. The mRNA profile showed that NSCs 
are themselves heterogeneous. Furthermore, I identified candidate genes and 
signalling pathways which could play important roles in NSC biology. 
Overall, this thesis describes the identification and characterization of NSCs 
and NPs using single-cell analysis. 
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Abbreviation   
3D 3-dimensional 
aNSC adult neural stem cell 
APC allophycocyanin 
ApoE Apolipoprotein E 
BDNF brain-derived neurotrophic factor 
bFGF basic fibroblast growth factor 
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BLBP brain lipid binding protein 
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CSPG chondroitin sulphate proteoglycan 
DAPI 4’,6’-diamidino-2-phenylindole dihydrochloride 
DG  dentate gyrus 
DMEM Dulbecco’s Modified Eagle’s Medium  
DN  double negative 
DP  double positive 
E (when describing embryonic 
stage) embryonic day 
ECM  extracellular matrix 
EGF epidermal growth factor 
EGFR epidermal growth factor receptor 
eNSC  embryonic neural stem cell 
ESC embryonic stem cell 
FACS fluorescence activated cell sorting 
FGFR fibroblast growth factor receptor  
FITC fluorescein isothiocyanate  
FSC forward scatter 
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GFP green fluorescence protein 
GLAST glutamate aspartate transporter 
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iPSC induced pluripotent stem cell 
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S (in cluster labelling) size/granularity 
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SGZ subgranular zone 
Shh Sonic hedgehog 
SSC side scatter 
SSEA-1 stage-specific embryonic antigen-1  
SVZ subventricular zone 
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1.1 Development of the mammalian embryo 
The development of a mammalian embryo begins after fertilization of 
the egg and formation of a zygote. The zygote undergoes three rounds of 
mitotic divisions to form an 8-cell structure known as a blastula (reviewed in 
[1, 2]). Individual cells within the blastula are termed as blastomeres. The 
blastula undergoes one more round of division to form a 16-cell structure 
known as a morula. At the morula stage, cells are specified into two types – 
internal and external. The internal and external cells are specified to be the 
precursors of the inner cell mass (ICM) and the precursors of the trophoblast 
respectively. The morula divides further eventually reaching the 64-cell stage. 
At this stage, the internal cells alter their shape and tightly position themselves 
to form the ICM. This also enables formation of a fluid-filled cavity known as 
the blastocoel. The external cells form the trophoblast, a layer surrounding the 
ICM and blastocoel. The trophoblast, ICM and blastocoel together make up 
the blastocyst. 
As development proceeds, the trophoblast cells secrete enzymes which 
digest the uterine lining to create a site for implantation. Following 
implantation, the trophoblast cells initiate formation of the placenta which 
allows for exchange of oxygen, carbon dioxide, nutrients and metabolic waste 
products between the maternal and fetal blood. The cells of the ICM are 
categorized into two groups – the hypoblast and epiblast. The hypoblast cells 
lead to formation of the yolk sac while the epiblast cells invaginate to form the 
primitive streak which marks the site of gastrulation. 
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During gastrulation, cells of the ICM are reorganized to give rise to the 
three germ layers – ectoderm, mesoderm and endoderm. The embryo is known 
as the gastrula at this stage. These three germ layers undergo differentiation 
and eventually give rise to all fetal tissue types (Figure 1.1). The ectoderm 
cells give rise to all neural tissues and the skin. The mesoderm cells lead to the 
formation of the heart, skeletal muscles, cartilage, bone, connective tissue, 
kidney and the hematopoietic system. The endoderm cells are responsible for 




Figure 1.1 Early embryonic development. 
After fertilization, the zygote divides to eventually form a blastocyst. The 
blastocyst undergoes gastrulation and develops into a gastrula. The gastrula 
contains the three germ layers, ectoderm, mesoderm and endoderm, which 




1.2 Development of the central nervous system 
1.2.1 Neurulation 
The development of the central nervous system (CNS) begins during 
gastrulation. At late gastrulation, the mesoderm cells invaginate at the 
primitive streak to form the notochord which extends along the anterior-
posterior axis and marks the embryonic midline. At this point, the 
neuroectodermal cells that are positioned above the notochord eventually 
generate the CNS. The notochord releases signals to the neuroectoderm to 
stimulate differentiation of a portion of the neuroectoderm into neural 
precursor cells. The neuroectodermal cells at the midline then develop into 
neuroepithelial cells with columnar morphology to form the neural plate. This 
process is termed as neurulation (Figure 1.2). The lateral sides of the neural 
plate then fold inwards to form the neural tube which further develops into the 
brain and spinal cord. 
The neural precursor cells of the neural tube are highly proliferative 
and divide to give rise to neuroblasts that exit the cell cycle and differentiate 
into neurons. Meanwhile, cells at the ventral midline of the neural tube receive 
signals from the notochord and differentiate into epithelial-like cells to form 
the floorplate. The presence of the floorplate is important for specifying the 
dorso-ventral axis of the neural tube. The floorplate also releases signals 
which stimulate differentiation of the ventral cells of the neural tube into 
spinal and hindbrain motor neurons. Neural precursor cells towards the dorsal 
side differentiate into sensory neurons of the spinal cord and hindbrain. At the 
extreme dorsal side where the lateral sides of the neural plate merge, the 
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neural precursor cells differentiate into a unique population known as the 
neural crest cells. These cells migrate from the neural tube and eventually give 
rise to a variety of neural cells such as the neurons of the enteric nervous 
system and neurosecretory cells of the adrenal gland and non-neural cells such 
as bone, cartilage and pigment cells. As development continues, the mesoderm 
next to the neural tube partitions into somites which form the axial 
musculature and skeleton. The portion of the neural tube adjacent to the 
somites develops into the primitive spinal cord. The anterior neural plate then 























Figure 1.2 Neurulation in mammalian embryo. 
Dorsal views of the embryo at different stages of development are shown; each boxed view is a midline cross section through the 
embryo at the same stage. (A) During the early phase of neurulation, the mesoderm at the primitive streak invaginates to form the 
notochord. (B) The neural plate then invaginates and gives rise to the neural tube. The part of the neural plate just above the 
notochord differentiates into the floorplate. The neural crest develops at the lateral edges of the neural plate at the region furthest 
from the notochord. (C) As neurulation continues, formation of the neural tube completes. The mesoderm adjacent to the neural 
tube divides into structures known as somites. (D) The neural tube forms the rudimentary spinal cord while the neural crest 
contributes to sensory and autonomic ganglia. The neural plate further expands at the anterior ends to eventually give rise to the 
brain. Adapted from Purves et al., 2001 [3]. 
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1.2.2 Specification of regions in the developing brain 
The major regions of the brain are specified through a series of 
morphogenetic changes of the neural tube (Figure 1.3). At first, the anterior 
and posterior ends of the neural tube bend to adopt the shape of a cane. The 
anterior end of the cane then expands in size to form the prosencephalon, the 
rudimentary forebrain. The region where the neural tube sharply bends, also 
known as the cephalic flexure, develops into the mesencephalon, the 
rudimentary midbrain. The region between the anterior and posterior cephalic 
flexures develops into the rhombencephalon, the rudimentary hindbrain. The 
remaining posterior end of the neural tube develops into the spinal cord. The 
luminal spaces enclosed by the regions of the developing brain give rise to the 
ventricles.  
As development proceeds, the prosencephalon and rhombencephalon 
further subdivide into two regions each. The anterior and posterior sections of 
the prosencephalon develop into the telencephalon and diencephalon 
respectively. The telencephalon eventually gives rise to the cerebral cortex, 
hippocampus, basal ganglia, basal forebrain nuclei and olfactory bulb while 
the diencephalon gives rise to the thalamus and hypothalamus. The anterior 
and posterior sections of the rhombencephalon develop into the 
metencephalon and myelencephalon respectively. The metencephalon gives 





Figure 1.3 Specification of regions in the developing brain.  
(A) During early development, the neural tube adopts a cane-like shape and 
subdivides into the prosencephalon, mesencephalon, and rhombencephalon. 
The spinal cord develops from the posterior end of the neural tube. Below is a 
longitudinal section of the neural tube at this stage. (B) The prosencephalon 
subdivides into the telencephalon and diencephalon and the rhombencephalon 
subdivides into the metencephalon and myelencephalon. These subregions 
give rise to the major functional subdivisions of the brain, while the spaces 
they enclose form the ventricles in the mature brain. Below is a longitudinal 
section of the embryo at this stage. (C) The major functional subdivisions such 
as the cerebral cortex and cerebellum are eventually formed and can be seen 






1.3 Stem cells 
Stem cells refer to cells which fulfill two main characteristics. First, a 
stem cell should be able to self-renew which is the ability to divide to produce 
daughter cells identical to the stem cell itself. Second, a stem cell should be 
able to differentiate into a variety of tissue types. Stem cells are generally 
classified into two types – embryonic stem cells (ESCs) and adult stem cells. 
In addition, induced pluripotent stem cells (iPSCs) represent a type of 
experimentally-derived stem cells.  
1.3.1 Embryonic stem cells 
ESCs are derived from the ICM of the blastocyst and are able to 
replicate indefinitely. ESCs up till the 8-cell stage are totipotent, which refers 
to their ability to give rise to all differentiated tissue types in an organism 
including the extraembryonic tissue. After the 8-cell stage, ESCs turn 
pluripotent as they are able to differentiate into all tissue types except the 
extraembryonic tissue. The history of ESC research (reviewed in [4]) began in 
the 1950s with the observation of teratocarcinomas, which are tumors 
consisting of a mixture of adult tissues and organs including teeth, bone, 
muscles, skin and hair [5]. These tumors had the ability to divide rapidly upon 
transplantation. More importantly, it was later demonstrated that a single cell 
derived from the tumor was able to give rise to all the tissue types found in the 
teratocarcinoma, suggesting the existence of a pluripotent stem cell [6]. 
Furthermore, particular structures similar to the early embryo were observed 




With the development of feeder layers, Martin and Evans were able to 
propagate teratocarcinoma cell lines and they observed that specific cells with 
large nuclei and distinct nucleoli were able to give rise to teratocarcinomas 
upon transplantation [7-10]. These cells were later known as embryonal 
carcinoma cells. Interestingly, embryonal carcinoma cells were also derived 
from teratocarcinomas formed upon grafting of embryos to extra-uterine sites. 
This finding drove attempts to isolate similar pluripotent cells from within the 
embryo. In 1981, two groups independently cultured the first mouse ESC line 
derived from the ICM of delayed-implanting mouse blastocysts [11, 12]. More 
than a decade later, the first human ESCs were isolated by Bongso et al. in 
1994 [13] and the first human ESC line was derived by Thompson et al. in 
1998 [14]. The pluripotent nature of ESCs allows these cells to have potential 
applications in therapeutics, research and disease modeling. However, use of 
ESCs in these applications has been hampered by ethical issues involved in 
creation and destruction of human embryos [15] and safety issues such as 
formation of tumors and donor-host rejection after ESC transplantation.  
1.3.2 Adult stem cells 
Adult stem cells are undifferentiated cells residing in specific locations 
in various organs. These cells are able to self-renew and are usually 
multipotent which refers to the ability to differentiate into a few cell types, 
usually confined to those found in the specific organ. The main function of 
adult stem cells revolves around repair and regeneration of tissues. Cells of 
specific types need to be generated during organ development and for 
replenishment after injury. Thus the adult stem cells in the organ are activated 
and undergo a series of cell divisions to produce progenitor cells which then 
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differentiate into the required cell types. Adult stem cells have been isolated 
from various tissues including the intestines, muscles, skin and bone marrow.  
Adult stem cells have their disadvantages and advantages over ESCs. 
In contrast to ESCs, adult stem cells can only differentiate into a few cell 
types. This poses a major limitation to the use of adult stem cells for 
generation of a variety of tissues for therapeutic purposes. However, recent 
studies suggest that stem cells in a tissue from a specific germ layer such as 
the mesoderm-derived bone marrow can transdifferentiate into a tissue from 
another germ layer such as the endoderm-derived liver, hence expanding their 
differentiation potential [16].  ESCs can be propagated in culture easily while 
adult stem cells have limited proliferative capacity. Moreover, adult stem cells 
are more challenging to isolate due to their limited population in tissues. This 
leads to a major obstacle in the use of adult stem cells in replacement therapies 
where large cell numbers are required. 
Despite these limitations, adult stem cells still hold great promise for 
use in cell replacement therapies. Adult stem cells from a patient can be 
isolated, differentiated and transplanted back to the same patient, hence 
reducing the chances of immune rejection. In addition, use of adult stem cells 
circumvents ethical issues associated with ESCs since it does not involve work 
on human embryos. 
1.3.3 Induced pluripotent stem cells 
The generation of iPSCs represents one of the most groundbreaking 
discoveries in stem cell research. Yamanaka’s group designed a screen of 24 
genes associated with pluripotency to assess their ability to activate a drug 
resistance allele at the ESC-specific Fbxo15 locus [17]. They found that when 
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all 24 factors were expressed in mouse fibroblasts, the Fbxo15 locus was 
activated resulting in the generation of drug-resistant iPSC colonies [18]. 
Further rounds of screening identified four key genes (also known as the 
Yamanaka factors), Sox2, Oct4, Klf12 and c-Myc, which constitute the 
minimal set of genes that could reprogram fibroblasts into iPSCs. Importantly, 
iPSCs exhibited features of pluripotency such as expression of pluripotent 
markers SSEA-1 and Nanog, teratoma formation upon injection into 
immunocompromised mice and differentiation into various tissue types 
following blastocyst injection [18]. 
Initially, iPSCs showed some differences to ESCs. iPSCs had lower 
expression of certain pluripotency genes as compared to ESCs, had different 
methylation patterns of Oct4, could not produce postnatal chimeras and did 
not contribute to the germline [18]. These observations indicated that the 
iPSCs were only partially reprogrammed. This prompted many groups to 
modify the reprogramming strategy and they were able to derive iPSCs which 
were more ESC-like in terms of molecular and functional characteristics [19-
21]. iPSCs have been derived from a number of species including humans [22-
24], rats [25] and Rhesus monkey [26]. 
iPSCs could be an exciting tool to be used in cell therapy, drug 
development and disease modeling (reviewed in [27]). Tissue replacement 
therapy is often hampered by the limited availability of immunocompatible 
donors. iPSCs help circumvent this problem as somatic cells such as skin 
fibroblasts from the patient can be reprogrammed into patient-specific iPSCs 
which are then differentiated into the required tissue type. This tissue type 
would genetically match the patient and drastically reduce the chances of 
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immunorejection. In addition, disease-causing mutations could be corrected in 
iPSCs using homologous recombination enabling the generation of disease-
free tissue types. This was demonstrated in a study where iPSCs were 
generated from skin cells from a mouse model for sickle-cell anemia [28]. The 
disease-causing point mutation was corrected in the iPSCs by gene targeting 
and the iPSCs were subsequently differentiated into blood progenitors. Upon 
transplantation into the mouse model, the blood progenitors led to the 
formation of healthy red blood cells and cured the mice. Hence iPSCs are 
more advantageous than adult stem cells since it is challenging to correct 
mutations in adult stem cells due to their limited proliferation in culture. iPSCs 
also hold an advantage over ESCs where ethical issues are concerned as the 
need for human embryos is eliminated. 
iPSCs aid in disease modeling for development of drugs and research. 
Somatic cells from the patient could be used to generate iPSCs which are 
predisposed to the disease. These iPSCs could be differentiated into the 
diseased tissue type. This provides a major advantage in creating models for 
diseases where the affected tissue type is depleted in the patient. The diseased 
tissue type generated could then be used for drug screens and to investigate 
disease mechanisms. Furthermore, in most degenerative diseases, the tissues 
would be at an advanced stage of the disease at the time of diagnosis. Thus 
researchers would not be able to study the mechanisms during the onset or 
early stages of the disease. iPSCs, however, would probably go through the 
early differentiation stages and thus would help recapitulate the initial stages 
of the disease. To date, iPSCs have been generated from patients suffering 
from various diseases including Huntington's and Parkinson's disease, Fanconi 
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anemia, amyotrophic lateral sclerosis, muscular dystrophy, Down syndrome 
and juvenile diabetes [29-32]. 
Despite the advantages offered by iPSCs, a few safety issues remain to 
be addressed. First, iPSCs could form teratomas and use of viral particles to 
generate iPSCs could raise concerns. Second, usually not all somatic cells are 
completely reprogrammed which leads to the presence of contaminant 
differentiated cells. Third, integrating vectors are used in the generation of 
iPSCs and thus endogenous genes may be affected and silencing the integrated 
genes may be difficult. Generation of iPSCs using viral-free methods such as 
direct delivery of reprogramming proteins and selection strategies to eliminate 
differentiated cells help tackle the safety issues described above [33-37]. 
1.4 Neural stem cells 
1.4.1 Embryonic neural stem cells  
Neural stem cells (NSCs) are undifferentiated cells of the CNS which 
have the following three characteristics: (1) ability to self-renew which is to 
give rise to daughter NSCs to sustain their population; (2) multipotency which 
is the ability to differentiate into the major neural lineages namely astrocytes, 
neurons and oligodendrocytes; (3) ability to regenerate tissue after injury in 
the CNS. NSCs are present since the beginning of embryonic forebrain 
development and persist in the adult brain. 
The development of the embryonic forebrain (Figure 1.4) (reviewed in 
[38, 39]) begins with a single layer of cells known as the neuroepithelial cells. 
These cells reside in the ventricular region and adopt a radial morphology, 
extending into the pial region. The neuroepithelial cells, also known as 
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primitive NSCs, express nestin [40] and are able to give rise to neurons, 
astrocytes and oligodendrocytes, thus representing the first embryonic NSC 
(eNSC) population. These cells exhibit polarity along the apical-basal axis as 
evident from certain characteristics [41, 42]. For instance, expression of 
Prominin-1 [43, 44], tight junctions and adherent junctions occur at the apical 
end [45-47] while expression of specific receptors such as integrin-α6 occurs 
at the basal end [41]. Interkinetic nuclear migration (migration of nucleus 
along the apical-basal axis during cell division) occurs in neuroepithelial cells. 
The neuroepithelial cells proliferate rapidly and together with their daughter 
cells, form the ventricular zone (VZ). At first, the neuroepithelial cells divide 
symmetrically to produce identical daughter cells to expand the NSC 
population at the VZ. Later during development, the neuroepithelial cells 
divide asymmetrically to generate daughter cells which undergoes radial 
migration [48]. Such asymmetric division and migration confers thickness to 
the developing brain. 
At the onset of neurogenesis, another distinct population of cells 
known as the radial-glial cells (RGCs) emerge. The RGCs are thought to 
originate from the dividing neuroepithelial cells. The RGCs possess unique 
basal processes which radially extend into the pial surface. The RGCs display 
both similar and distinct characteristics as compared to neuroepithelial cells 
(reviewed in [38, 49]). Similar to the neuroepithelial cells, the RGCs express 
Prominin-1 [43] and nestin [50], contain adherent junctions at the apical side 
and show inter-kinetic nuclear migration. However, unlike the neuroepithelial 
cells, the RGCs are more fate-restricted [51, 52] and display astroglial 
properties. In most cases, RGCs give rise to neurons and in fact, most of the 
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neurons in the brain are derived from RGCs [49, 53]. The RGCs also show 
astroglial features such as expression of glutamate-aspartate transporter 
(GLAST), glial fibrillary acidic protein (GFAP), brain lipid binding protein 
(BLBP) and S100β [54-56].  
The neuroepithelial cells and RGCs are collectively known as the 
apical progenitors based on their location towards the apical surface and these 
cells are widely regarded as the eNSCs in vivo. The RGCs persist in the 
neonatal brain and give rise to ependymal cells, olfactory bulb interneurons, 
oligodendrocytes and astrocytes of which some function as NSCs in the adult 
brain. The RGCs disappear soon after birth in mammals, but remain in the 
adult brain in many other species such as turtles [57], lizards [58], fish [59] 
and songbirds [60]. 
Over the course of neurogenesis, the apical progenitors divide to give 
rise to the young basal and basal progenitors [48, 61-63]. The main difference 
between the apical and basal progenitors is that the apical progenitor nuclei 
divide at the apical end of the VZ while the basal progenitor nuclei divide at 
the basal side of the VZ [48, 61, 62]. In addition, the basal progenitors express 
specific genes such as Svet1 [64], Tbr2 [65], Cux1 and Cux2 [66, 67]. 
Eventually, the basal progenitors migrate outwards and form the 
subventricular zone (SVZ), a region of cells basal to the VZ. The basal 
progenitors then divide symmetrically in the SVZ and generate neurons [48]. 
Importantly, the basal progenitors contribute to brain size as species with 
bigger brains tend to have higher numbers of these progenitors [68]. 
The generation of the three major neural lineages from eNSCs occurs 
in a sequential manner. During embryonic development, neurogenesis begins 
32 
 
first followed by gliogenesis. In mice, neurogenesis begins at E12, peaks at 
E15 and ends at around birth [69]. As for gliogenesis, astrocytes and 
oligodendrocytes are observed at E16 and at around birth respectively [70, 




Figure 1.4 NSCs in the developing forebrain.  
(A) During early development, the NSCs (shown in blue) begin as 
neuroepithelial cells and divide symmetrically at the VZ to expand the NSC 
pool. (B) The neuroepithelial cells then develop into RGCs. NSCs produce 
neurons and oligodendrocytes either directly or via an intermediate progenitor 
(shown in green) in the SVZ. The extended processes of RGCs help in 
neuroblast (shown in red) migration. (C) NSCs persist in the neonatal brain 
and generate oligodendrocytes, neurons and astrocytes of which some function 
as NSCs in the adult brain. (D) In the adult brain, neurogenic astrocytes often 
possess a radial process and generate oligodendrocytes and olfactory bulb 
interneurons. Abbreviations: NSC, neural stem cells; VZ, ventricular zone; 
RGC, radial glial cell; SVZ, subventricular zone; Stri, striatum. Adapted from 








1.4.2 Adult neural stem cells 
It was previously thought that the brain lacked the ability to regenerate 
and produce new neurons after birth as described by Ramon y Cajal’s “no new 
neurons after birth” theory. However, a series of critical findings changed how 
the brain’s regenerative capacity was being perceived and showed evidence 
for the existence of adult NSCs (aNSCs). It began in the 1960s when labelling 
using [3H]-thymidine hinted at the production of neurons in the dentate gyrus 
(DG) of the hippocampus and presence of proliferating cells in the SVZ which 
appeared to migrate to the olfactory bulb [73]. In the 1970s, Michael Kaplan 
and James Hinds used electron microscopy and autoradiography to confirm 
that the new cells generated in the DG and the olfactory bulb were granule 
neurons capable of forming synapses with neighbouring cells. Further 
experiments with canaries validated the birth of new neurons in adult CNS. 
For instance, testosterone-treated female canaries were injected with [3H]-
thymidine and new neurons were detected in the lateral ventricle [74].  
In the 1990s, Elizabeth Bould found that cells with neuronal 
morphology were generated in the rat hippocampus upon adrenal hormone 
treatment. In addition, Reynolds and Weiss demonstrated that adult cortical 
cells could be propagated in vitro and differentiated into the three major neural 
lineages [75]. These two findings prompted the search for evidence for 
neurogenesis in the adult SVZ and DG [76-80]. It was finally demonstrated by 
Fred Gage’s group that neurogenesis occurs in the adult human hippocampus 
[81]. A recent study measured the degree of neurogenesis in the human 
hippocampus [82]. In this study, the level of nuclear-bomb-test- derived 14C in 
human hippocampal neurons was used to date the neurons and an annual cell 
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turnover of 1.75% was reported. This rate is suggested to contribute to brain 
function. At present it is generally accepted that aNSCs exist in the two 
neurogenic regions, the adult SVZ of the striatum and subgranular zone (SGZ) 
of the hippocampus. Other potential regions of neurogenesis such as the 
hypothalamus and amygdala are being investigated for aNSCs [83]. 
In the adult SVZ, it is widely accepted that GFAP-expressing NSCs 
known as Type B cells exist [84]. Type B cells divide and give rise to Type C 
transit amplifying cells with higher proliferation. Type C cells in turn give rise 
to Type A neuroblasts which migrate to the olfactory bulb via the rostral 
migratory stream before differentiating into neurons [85]. In addition, Type B 
cells contribute to the oligodendrocytes present in striatum, corpus callosum 
and fimbria fornix [86]. Another school of thought is that two cell populations 
exist in the adult SVZ – a constitutively proliferating and a relatively quiescent 
population. It was found that the relatively quiescent population are the NSCs 
in the SVZ [87].  
In the neurogenic regions of the hippocampus, two cell types exist. 
Type 1 cells express Sox2 and GFAP and adopt a radial-glial-like 
morphology. Type 2 cells do not express GFAP and do not have radial-glial 
morphology. Both cell types contribute to neuroblast and neuron formation in 
the hippocampus but the exact relationship between Type 1 and 2 cells is yet 
to be determined [88]. 
aNSCs have astrocytic characteristics in contrast to eNSCs. Depletion 
of GFAP-expressing proliferative cells seemed to abolish the NSC population 
in the adult brain but not in the embryonic brain [89, 90]. Furthermore, aNSCs 
adopt a radial-glial-like morphology suggesting that these cells originate from 
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RGCs. This was confirmed in a study which showed that RGCs give rise to 
astrocytic cells which in turn function as aNSCs [91]. 
1.5 Neural progenitors 
Neural progenitors (NPs) are daughter cells of NSCs. Under both in vitro and 
in vivo conditions, NSCs undergo two types of division - symmetric and 
asymmetric. During symmetric division, an NSC divides to give rise to two 
NSCs which help expand the NSC population. In contrast, during asymmetric 
division, an NSC divides to give rise to a NSC and an NP. The NP then exits 
the cell cycle and differentiates into the different neural lineages. All cells 
which occur between NSCs and terminally differentiated neurons and glia can 
be termed as NPs. NPs differ from NSCs in their capacity to self-renew and 
proliferate and in their differentiation potential. Unlike NSCs, NPs have 
limited ability to self-renew and usually have reduced proliferative capacity as 
these cells are committed towards differentiation. NPs are also more restricted 
in their differentiation potential compared to NSCs. NPs could be neuron-
restricted or glia-restricted progenitors and hence are either bipotent or 
unipotent compared to NSCs which are tripotent. 
1.6 The culture of neural stem cells 
1.6.1 Neurosphere culture system 
The neurosphere culture system was developed as a means to 
propagate NSCs in vitro through the pioneering work of Reynolds and Weiss 
in the early 1990s. In their initial study in 1992, Reynolds and Weiss isolated 
striatal cells from the adult mouse brain and used epidermal growth factor 
(EGF) to stimulate proliferation of these cells in culture [75]. Free-floating 
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clusters of cells, termed as neurospheres, were formed as the cells divided. 
The cells in culture expressed nestin and could be differentiated into neurons 
and astrocytes. Subsequently in the same year, Reynolds’ group showed that 
cells isolated from E14 mouse striatum could also proliferate and form 
neurospheres in the presence of EGF [92]. Similar to the adult counterparts, 
the embryonic striatal cells expressed nestin and could differentiate into 
neurons and astrocytes. In a later study, it was demonstrated that the 
embryonic striatal cells could also differentiate into oligodendrocytes [93]. 
These findings proposed that NSCs could be propagated in vitro as 
neurospheres. Interestingly, cells from other parts of the CNS such as the adult 
mouse thoracic spinal cord could also generate neurospheres in the presence of 
EGF and basic fibroblast growth factor (bFGF), suggesting that NSCs could 
reside in these regions [94]. 
1.6.2 Structure of neurospheres 
Neurospheres have a 3-dimensional (3D) structure which enables the 
cells to be in an environment that closely resembles the NSC niche in vivo. A 
cell in a neurosphere is closely surrounded by neighbouring cells and thus 
maintains cell-cell contacts. In addition, concentration gradients of nutrients 
and growth factors across the neurosphere resemble the dynamic character of 
the physiological environment. Cells in the neurosphere are surrounded by a 
rich extra-cellular matrix (ECM) whose components are synthesized and 
secreted by the cells themselves [95]. The ECM components include laminins, 
fibronectin and chondroitin sulphate proteoglycans (CSPGs). Cells in the 
neurosphere also express high levels of β1-integrins, growth factor receptors 
and cadherins for adhesion and proliferation [95-97].  
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In 2003, Bez et al. performed extensive characterization of the 
ultrastructure of human fetal neurospheres [98]. Her group observed that 
neurospheres were heterogeneous at both the sphere and cellular level. Some 
neurospheres were spherical while other neurospheres were irregular in shape. 
Neurospheres also had varying sizes, with larger spheres having a dark inner 
core and smaller spheres having a more translucent appearance. 
Cytofluorimetric analysis revealed morphological heterogeneity at the 
cellular level. The cells within the neurospheres differed in their size and 
granularity. Differences were also observed in the number and distribution of 
active mitochondria. Further characterization using electron microscopy also 
revealed functional heterogeneity at the cellular level. Generally, the cells 
were at different stages of the cell cycle and thus were not synchronized. In 
addition, the occurrence of processes such as mitosis, apoptosis and 
phagocytosis varied according to the position of the cell within the 
neurosphere. Proliferation was prevalent at the periphery compared to the 
interior of the neurospheres. Apoptosis on the other hand, was prevalent at the 
inner core of the neurosphere. Phagocytosis of apoptotic cells, necrosis and 
presence of lysosomes mostly occurred at the inner core. The findings by 
Bez’s group drew similarities with observations made using neurospheres 
from rat fetal striatum [95].  
1.6.3 Growth factors and neurospheres 
Growth factors play an important role in establishing the neurosphere 
culture system as a tool to propagate NSCs. In their initial studies in 1992, 
Reynolds and Weiss used EGF to generate neurospheres from the adult and 
embryonic striatum [75, 92]. A year later, it was found that EGF- generated 
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neurospheres derived from E14 mouse striatal cells express fibroblast growth 
factor receptor (FGFR) 1 [99]. Addition of its ligand bFGF could stimulate 
proliferation of bipotent and unipotent NPs, suggesting that bFGF acts on 
more restricted NPs. Further characterization revealed that EGF-generated 
neurospheres also express TrkB, a receptor for brain-derived neurotrophic 
factor (BDNF) [100]. It was found that addition of BDNF induced 
differentiation and maturation of neurons. These findings indicate that a 
variety of growth factors are needed to maintain the different populations 
within neurospheres. Perhaps each growth factor has its target population and 
regulates specific processes such as proliferation and differentiation. At 
present, both EGF and bFGF are now commonly used components of the 
neurosphere growth medium although other factors such as nerve growth 
factor [101] and heparin [102, 103] are used at times.  
It was found that NSCs/NPs from embryos of different developmental 
stages have varying requirements for EGF and bFGF. Neurospheres could be 
generated from E8.5 anterior neural plate tissue and E14 striatum in the 
presence of bFGF but not EGF [104, 105]. These cells then turn EGF-
responsive in vitro suggesting that the requirement for bFGF precedes that of 
EGF. This corroborates with the observation that as cells transit from E13.5 to 
E14.5 to E15.5, they express more EGF receptor (EGFR) [106, 107] and thus 
become more EGF-responsive while sustaining bFGF-responsiveness [104]. 
Apart from growth factors, two media supplements often used in 
culturing neurospheres are N2 and B27. N2 contains insulin, transferrin, 
progesterone, putrescine and selenite while B27 contains additional factors 
such as vitamins and anti-oxidants which promote neuronal survival [108]. 
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While both supplements are comparable in terms of efficiency of culturing 
NPs at bulk density [109], B27 seems to have an edge in culturing 
neurospheres at clonal density [110]. 
1.7 Quantification of neural stem cells 
The neurosphere culture system was developed not only to propagate 
NSCs but also to quantify NSCs. An NSC in culture has to meet three 
important criteria – extensive self-renewal, proliferation and multipotency. 
Thus the question arises on how accurately the neurosphere culture system 
could be used to enumerate cells which meet these criteria. To answer this 
question, the relationship between neurospheres and NSCs has to be evaluated 
(reviewed in [111]). 
1.7.1 Neurosphere formation assay 
Initial studies used the neurosphere formation assay (NFA) to 
enumerate NSC frequency [112-114]. Dissociated cells were plated for 
neurosphere formation and the number of neurospheres formed for every 100 
cells plated was determined. This value is termed as the neurosphere formation 
unit (NFU). The NFU would reflect the NSC frequency based on the 
assumption that each neurosphere arises from one NSC. However, later studies 
suggested that this assumption is not true. Reynolds and Rietze demonstrated 
that the NFA indeed overestimates the actual NSC frequency by an order of 
magnitude [111]. This finding also suggests that apart from NSCs, some NPs 
could also generate neurospheres. Thus, solely using neurosphere formation to 




1.7.2 Secondary neurosphere formation assay 
The self-renewal capacity of a cell is evaluated based on its ability to 
generate secondary neurospheres after dissociation and replating of the 
primary neurospheres. When neurospheres are dissociated and replated, most 
of the cells do not survive due to the culture conditions which fail to support 
long-term survival of these cells. NSCs which are EGF- and bFGF- responsive 
usually survive for at least ten passages and thus display extensive self-
renewal capacity in culture [93, 115-117]. NPs which are EGF- and bFGF- 
responsive could also generate neurospheres for a few passages but not for an 
extended time. Hence it has been widely accepted that bona fide NSCs can be 
enumerated with fair accuracy based on neurosphere formation for at least ten 
passages. In most studies however, self-renewal ability is usually measured 
based on secondary or tertiary neurosphere formation due to the long 
experimental time required for ten passages. It has to be noted that the 
secondary NFA can be used to broadly compare the self-renewal ability 
between populations but cannot be used to accurately enumerate NSC 
frequency.  
1.7.3 Neural stem cell proliferation assay 
To define an NSC, the other criterion that can be evaluated is the high 
proliferative capacity which generates a large number of progeny. However, 
the question of how many is considered as a “large” number arises. While it 
can be argued that even thousands of progeny could be considered as “large”, 
NSCs are able to generate billions of progeny [93, 115, 117, 118]. This 
property of NSCs was used by Louis et al. to develop a commonly used assay 
for NSC enumeration – the neural colony-forming cell assay (NCFCA) [119]. 
42 
 
In this assay, single cells are cultured for 21 days in a collagen-containing 
semisolid matrix and those cells that form neurospheres above 2mm in 
diameter are defined as NSCs. It was shown that only neurospheres above 
2mm in diameter were tripotent. Therefore, the NSCs are effectively 
distinguished from NPs based on their proliferative potential and thus allows 
for NSC enumeration. 
1.7.4 Multipotency assay 
The third characteristic of an NSC is its ability to differentiate into 
astrocytes, oligodendrocytes and neurons. In the multipotency assay, growth 
factors are removed and serum is added to the culture medium to differentiate 
the neurospheres, and if all three neural lineages are observed in a neurosphere 
after differentiation, then the cell that initiated that neurosphere is an NSC. 
However, the multipotency assay has some limitations. First, the culture 
conditions used for differentiation may not be optimal for generation of all 
three neural lineages. In fact, in single neurosphere differentiation, significant 
cell death occurs and mostly astrocyte generation occurs. Using conditioned 
medium instead seems to support generation of neurons and oligodendrocytes 
(Muly Tham and Sohail Ahmed, unpublished).  Second, the length of time 
given for differentiation has to be determined with caution. Short 
differentiation periods do not give enough time for a cell to exhibit its 
differentiation potential while long differentiation periods may result in cell 
death. Thus careful considerations have to be given to the culture conditions 
before performing the multipotency assay. 
The multipotency assay in combination with the NFA can be used to 
enumerate NSCs in a given population as exemplified in two recent studies 
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[120, 121]. This is based on the definition of an NSC in vitro to be a cell that 
gives rise to a neurosphere which in turn generates the three neural lineages 
upon differentiation. First, the NFA is performed to determine the NFU. Then 
the neurospheres formed are differentiated and the percentage of tripotent 
neurospheres is determined. The product of the NFU and the percentage of 
tripotent neurospheres would then give the NSC frequency.  
1.7.5 Clonality 
One of the most critical factors that determine the accuracy of the NFA 
and multipotency assay is that both assays have to be performed under clonal 
conditions (Figure 1.5). Clonal conditions refer to culture set ups where each 
neurosphere arises from a single cell. In bulk suspension cultures, aggregation 
occurs at both cellular and neurosphere level [122-124]. Hence, it is possible 
for each neurosphere to arise from multiple cells or neurospheres which 
complicates neurosphere counting during the NFA. Recent evidence shows 
that aggregation of cells does not occur at low plating density of 0.5 cells/µl 
and below and when culture plates are not moved during neurosphere 
formation [122]. Thus culturing cells at such low density would ensure 
clonality. Clonality can also be established in gel-based systems such as the 
hydrogel system where cells are immobilized. 
Clonality has to be ensured during the multipotency assay as well. 
Neurospheres grown under clonal suspension conditions can be individually 
placed in wells of a 50-well chambered coverslip which prevents neurospheres 
from contacting each other during differentiation. The neurospheres are then 
scored for potency. Overall, the neurosphere culture system is a useful tool to 
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accurately enumerate NSCs, provided steps are taken to ensure optimal culture 
conditions and clonality. 
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 Figure 1.5 Clonal neurosphere growth and differentiation.  
(A) Cortical cells from E14.5 mouse are isolated and cultured to form 
neurospheres under bulk growth conditions. (B) The neurospheres are then 
dissociated and cells are plated at clonal density (1 cell/well) on a 96-well 
dish. (C) Clonal neurospheres are then placed in individual wells of 50-well 
coverslips and differentiated by inverting coverslips on to a 10 cm dish 
containing differentiating medium. Cells are then stained for (D) O4, (E) Tuj1 
and (F) GFAP to visualize oligodendrocytes, neurons and astrocytes 
respectively. (G) DAPI is used to stain nuclei. (H) An NSC in vitro is defined 
as a cell that gives rise to all three lineages under clonal conditions. Scale bar: 
(A, C and G) 100 µm; (B) 10 µm. Abbreviations: E, embryonic day; GFAP, 
glial fibrillary acidic protein; DAPI, 4’,6’-diamidino-2-phenylindole; NSC, 
neural stem cell. Adapted from Ramasamy et al., 2013 [125].  
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1.8 Neural stem cell markers 
NSC markers allow for the enrichment of NSCs. To date there are no 
definitive markers to help isolate a pure NSC population in vitro. This would 
also mean that there is a lack of markers that distinguish NSCs from NPs in 
vitro. The search for definitive NSC markers is urgent and ongoing. 
Nevertheless, a number of markers have been identified to be highly expressed 
in NSCs and help enrich for NSCs. Although these markers are selective 
rather than specific for NSCs, they are still termed as NSC markers as they 
have helped in studying NSC behavior and characteristics. Both in vitro and in 
vivo NSC markers have been identified and can be categorized as cell surface, 
intracellular and morphological. 
1.8.1 In vitro neural stem cell markers 
At present, LewisX (LeX) and CD133 are the most established cell 
surface NSC markers. LeX, also known as CD15 or stage-specific embryonic 
antigen (SSEA-1) is a glycan consisting of the minimal motif galactose β1-4 
and fucose α1-3-linked to N-acetyl glucosamine [126, 127]. LeX expressing 
cells from the embryonic brain have high neurosphere formation capacity and 
similar cells from the adult SVZ give rise to multipotent neurospheres, 
suggesting LeX to be a useful marker in both the embryonic and adult systems 
[126-128]. The exact functions of LeX in NSCs are not fully understood but it 
has been shown that LeX binds Wnt-1 and possibly presents Wnt-1 for self-
renewal and proliferation [126]. To date, a range of antibodies have been 
developed to detect the LeX antigen [127] although the exact epitope detected 
by these antibodies is still unclear.  
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CD133 (human homologue) or Prominin1 (homologue in rodents) was 
identified as an NSC marker in the SVZ. CD133+ve CD34−ve CD45−ve cells 
from human fetal brain tissue generated both primary and secondary 
neurospheres and differentiated into neural and glial cells, hence exhibiting 
self-renewal ability and multipotency [129]. Likewise, Prominin1+ve cells from 
mouse brain generated neurons and glia upon transplantation and expressed 
other NSC markers such as Sox1, Sox2, Musashi1 and Nestin [130]. These 
findings establish CD133/Prominin1 as an in vitro NSC marker. 
 Apart from LeX and CD133, other surface markers have been used to 
enrich for NSCs. Recently, fluorescence activated cell sorting (FACS) and 
image-based immunophenotyping analysis identified a signature of cell 
surface proteins (CD184+ve/CD271−ve/CD44−ve/CD24+ve) which enables 
enrichment of NSCs [131]. Notch1 [132], syndecan-1 [132], integrin-α6 [133], 
integrin-β1 [132-134], ABCG2 [114, 135, 136], CXCR4 [137, 138], FGFR4 
[139], Frizzled-9 [139], Glut1 [136] and Notch2 [140] add on to the list of cell 
surface NSC markers. 
CD93 is a promising NSC marker. CD93 is a 126kDa cell surface 
glycoprotein highly conserved across humans, mice, and rats [141, 142]. 
CD93 was initially identified as an early B cell marker and expressed on 
monocytes, neutrophils and endothelial cells [143]. During development of the 
mouse embryo, CD93 is expressed in three major cell types, namely the 
vascular endothelial cells, aorta-associated hematopoietic clusters and 
primitive fetal liver hematopoietic stem cells (HSCs). In the adult, CD93 is 
expressed in cells of the lung, heart and whole bone marrow [144]. Recent in 
vitro studies showed that CD93 is expressed during the early stages of 
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hematopoietic development [145, 146]. In addition, transplantation of a 
CD93+ve CD45R-ve subpopulation of differentiating ESCs into lymphoid-
deficient mice led to long-term reconstitution of both T and B lymphocytes 
and restoration of immune functions [147]. Taken together, CD93 expression 
defines a population of multipotent HSCs that can differentiate into all the 
different cell types of the blood system. It was recently demonstrated that 
CD93 is highly expressed in ischemic mouse brain and protects the brain after 
cerebral ischemia by suppression of neuroinflammatory response [148]. In 
addition, expression of CD93 was also detected in a subset of pyramidal 
neurons in human brain [149]. These observations suggest that CD93 has 
important functions in the brain. Recent studies demonstrated that the 
expression of CD93 could be used to enrich for NSCs in mouse embryonic 
neurospheres, suggesting that CD93 could be a NSC marker (Mike Yu and 
Sohail Ahmed, unpublished). 
The exact molecular function of CD93 is yet to be determined. It has 
been suggested that CD93 could be a receptor for the complement, C1q, which 
plays a role in C1q-mediated phagocytosis [150]. However, a study 
demonstrated that CD93 interacts with C1q only under non-physiological 
conditions. Hence, it does not appear to play a role in C1q-mediated 
phagocytosis. Instead, it is suggested that CD93 may contribute to the in vivo 
clearance of dying cells [151] and cell-cell adhesion [152].  
Other in vitro NSC markers include (i) intracellular and morphological 
markers such as (ii) dye exclusion and (iii) cell size and granularity. (i) Using 
Sox2-EGFP transgenic mice, multipotent neurospheres which could be 
passaged extensively were generated from EGFP-positive cells, indicating that 
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Sox2 is an intracellular NSC marker [153]. (ii) When cells from the embryonic 
and adult brain are stained with DNA-binding Hoechst 33342 dye, some cells 
which have increased expression of ABC transporters are able to pump out the 
dye. Upon FACS analysis, these cells appear at the “side” of the FACS profile 
distinct from the stained cells and hence are termed as the side population. It 
was observed that the side population is enriched with cells having NSC 
characteristics [114]. (iii) Under non-clonal conditions, Kim and Morshead 
found that bigger cells within the side-population were enriched with NSCs 
compared to the smaller cells [114]. Furthermore, cells with increased size and 
granularity had greater self-renewal ability and multipotency than cells with 
decreased size and granularity [113, 154]. This data suggests that both cell size 
and granularity can be used to enrich for NSCs. 
1.8.2 In vivo neural stem cell markers 
In mouse brain there appears to be three types of NSCs in the embryo 
and two types in the adult. Further work is necessary to establish the presence 
of these five types of NSCs. The first type of eNSCs are the primitive NSCs. 
Primitive NSCs occur at the neuroepithelium between E5.5 to E8.0. Nestin, an 
intermediate filament protein, and Sox2 are two important markers of 
primitive NSCs [40, 153, 155]. In addition, LeX is highly expressed in the 
proliferative cells in the neuroepithelium and seems to mark primitive NSCs 
[126]. 
The second type of eNSCs are the NSCs in the VZ (NSCs-VZ) which 
are derived from the primitive NSCs. Cells with radial morphology in the VZ 
are the proposed NSCs and these cells express high levels of LeX. Another 
marker of NSCs-VZ is CBF-1. CBF-1 is a transcription factor whose activity 
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is regulated by Notch signalling. In the VZ, CBF-1 expression is higher in the 
NSCs than in the NPs and thus is used to distinguish between these two cell 
types [156]. In another study, CBF1-responsive element- EGFP transgenic 
mice were used to report CBF-1 activity with GFP fluorescence as a read out. 
It was found that NSCs were enriched within the GFPhigh population as 
compared to GFPlow population in the VZ, suggesting CBF-1 marks NSCs in 
the VZ. Besides LeX and CBF-1, Prominin1 also serves as an NSC marker in 
the embryonic VZ. Cells with high expression of Prominin1 in the VZ had 
enhanced self-renewal capacity and were multipotent [130]. The next NSC 
marker in the VZ is Pax6, a transcription factor. Interestingly, NSCs seem to 
express a specific level of Pax6 as increased and decreased expression of Pax6 
lead to neurogenesis [157]. Pax6 expression also reduces over development as 
NSCs undergo differentiation [65].  
Another school of thought posits that in the embryonic brain, the 
NSCs-VZ comprise of neuroepithelial cells and RGCs. Hence RGC markers 
are also regarded as NSC markers. LeX functions as a prominent RGC marker 
in the developing human [158, 159], wallaby [160] and mouse CNS [161, 
162]. Other common RGC markers are vimentin [163, 164], BLBP [165-167], 
Ephrin B1 [168], RC2 [169, 170] and GLAST [171].  
The third type of eNSCs are found in the SVZ (NSCs-SVZ). Here 
nestin seems to distinguish the NSCs from the NPs. Cells with higher nestin 
expression have higher proliferative capacity, higher neurosphere formation 




In the adult brain, NSCs exist in two main regions – the SVZ of the 
striatum and the SGZ of the hippocampus. Cells of the SVZ reside beneath the 
ependymal layer and are also known as subependymal cells. EGF/EGFR and 
nestin are two major markers of these subependymal cells [173]. In addition, 
GFAP is highly expressed in cells with NSC features in the SVZ [84, 174]. 
Strikingly, when SVZ cells are abolished using cytosine arabinoside, the entire 
cell population is regenerated from GFAP-expressing astrocytes [174]. Similar 
with other types of NSCs, LeX also marks the adult subependymal cells and 
helps distinguish them from the ependymal cells [112].  
LeX also marks the NSCs in the hippocampus. It was found that LeX 
expression is strongest outside the DG, surrounding blood vessels and at the 
pial surface which agree with the proposed locations of NSCs in the 
hippocampus [112, 118]. Hence, LeX is a marker for both types of NSCs in 
the adult brain. 
1.9 Regulation of neural stem cells 
1.9.1 Notch signalling and related factors 
The Notch signalling pathway was originally discovered in Drosophila 
and is currently known to regulate numerous processes during embryonic 
development and in the adult [175, 176]. At present, the pathway has four 
receptors (Notch1-4) and five ligands (Jagged 1, Jagged 2, Delta-like 1, Delta-
like 3 and Delta-like 4), all of which are transmembrane proteins [177]. The 
ligand present on the membrane of a cell binds with the Notch receptor present 
on the membrane of a neighbouring cell. This interaction activates proteolytic 
cleavage of the Notch receptor by the enzyme γ-secretase [178, 179]. The 
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Notch intracellular domain (NICD) [180] is then released and is transported 
into the nucleus. The NICD then forms a transcriptional activator complex 
together with other transcriptional regulators such as CBF-1 and Mastermind 
[181] to regulate expression of a number of effector genes including Hes and 
Hey genes (Figure 1.6) [182]. 
Hes1 genes. Two important effectors of Notch signalling are the 
bHLH genes Hes1 and Hes5. Hes1 and Hes5 are transcriptional repressors 
which help maintain NSCs in their undifferentiated state [183, 184]. 
Interestingly, the dependence of eNSCs on Hes genes varies across 
development. eNSCs begin as Hes-independent neuroepithelial cells and then 
gain dependence on Hes genes to generate Hes-dependent RGCs [183]. 
Ablation of Hes1 and Hes5 expression leads to reduced secondary neurosphere 
formation [184, 185]. This indicates Hes1 and Hes5 are involved in NSC self-
renewal.  
Other findings suggest that Hes genes promote NSC proliferation. For 
instance, knockout of both Hes1 and Hes5 resulted in smaller neurospheres 
and knockdown of Hes1 led to lesser BrdU incorporation in neurospheres 
[184, 186]. In addition, overexpression of Hes1 stimulated cell proliferation in 
vitro [187].  
Hes genes are also involved in repression of differentiation. In Hes-
knockout embryos, premature differentiation of neurons occurs, indicating Hes 
genes inhibit NSC differentiation [183]. One of the proposed mechanisms by 
which NSC differentiation is repressed is that Hes genes bind to the promoter 
regions of proneural genes such as Mash1, Math3 and Ngn2 and inhibit their 
53 
 
expression and thus neurogenesis [188]. Taken together, Hes genes promote 
self-renewal and proliferation of NSCs while repressing differentiation. 
Hesr1 and Hesr2. Hes-related bHLH genes, Hesr1 and Hesr2 also 
function as effectors of Notch signalling. The main difference between Hes 
and Hesr proteins is that Hes proteins contain a conserved proline residue in 
the basic region but Hesr proteins do not. Hesr1 and Hesr2 downregulate 
proneuronal bHLH genes which leads to the maintenance of NSCs in the 
embryonic brain [189]. It also has been shown that Hesr proteins can form 
heterodimers with Hes proteins [190]. Perhaps Hesr and Hes proteins promote 
NSC maintenance in a synergistic manner. 
CBF-1. CBF-1 is a transcriptional regulator involved in Notch 
signalling. Mizutani et al. developed a transgenic system where CBF-1 
promoter activity was linked to EGFP reporter expression [156]. They found 
that cells with high EGFP expression had higher Hes1 and Hes5 expression 
and generated more multipotent neurospheres than cells with low EGFP 
expression. This suggests that high CBF-1 activity distinguishes NSCs from 
NPs. Knockdown of CBF-1 promotes an irreversible conversion of NSCs to 
NPs, indicating high CBF-1 activity is essential for NSC maintenance [156]. 
Furthermore, observations using CBF-1 conditional knockout system suggest 
CBF-1 represses NSC differentiation [191]. 
Musashi1. Musashi1 is a RNA-binding protein that is intricately 
linked to Notch signalling. Musashi1 binds to its target mRNA, mNumb, and 
represses its translation. mNumb is involved in the ubiquitination and 
subsequent degradation of the NICD of Notch1 receptor, thus acting as an 
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antagonist of Notch signalling. Hence, repression of mNumb by Musashi1 




Figure 1.6 Notch signalling pathway. 
The Notch receptor binds to one of its ligand such as Dll1. This activates 
cleavage of the intracellular domain of Notch by γ-secretase thus releasing the 
NICD. The NICD then enters the nucleus to form a complex with CBF1 and 
the transcriptional co-activator Maml. The NICD–CBF1–Maml complex 
induces the expression of Notch effector genes such as Hes1 and Hes5. Hes1 
and Hes5 then inhibit the expression of proneural genes such as Mash1 and 
Ngn2, which helps maintain NSCs. Abbreviations: NSC, neural stem cell; Dll, 











1.9.2 Wnt signalling and related factors 
Wnt signalling is another critical pathway in NSCs. The Wnt signalling 
pathway begins when the Wnt ligand secreted to the extracellular space binds 
to its receptor Frizzled and co-receptor Lrp5/6. Without this interaction, β-
catenin in the cell is bound to a multiprotein complex containing Axin. β-
catenin is then phosphorylated by casein kinase 1 and glycogen-synthase 
kinase- 3β which targets β-catenin for degradation by ubiquitination. However 
when Wnt binds to Frizzled, the intracellular scaffold protein Dishevelled is 
activated. Dishevelled enables the displacement of GSK-3β in the multiprotein 
complex which prevents subsequent phosphorylation and degradation of β-
catenin. This allows β-catenin to be sequestered in the cytoplasm and is then 
translocated into the nucleus. β-catenin replaces Groucho in the LEF/TCF 
transcription complex and activates transcription of Wnt target genes (Figure 
1.7). 
β-catenin. The main component of Wnt signalling pathway is β-
catenin. Conditional mutation of β-catenin led to loss of cells at the 
midhindbrain boundary and the NSC/NP population resulting in reduced brain 
size [193, 194]. In contrast, overexpression of β-catenin led to hypercellularity 
of the brain [195]. These findings indicate that β-catenin promotes NSC/NP 
proliferation. β-catenin also plays a role in differentiation [196]. It has been 
shown that β-catenin by itself promotes neuronal differentiation, while β-
catenin together with Fgf2 inhibits neuronal differentiation [197] suggesting 
that the Wnt signalling pathway controls the balance between NSC/NP 
proliferation and differentiation.  
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Wnt proteins. Wnt proteins promote NSC/NP proliferation as 
indicated from the following evidence. Addition of Wnt-3a and Wnt-5a 
promotes proliferation of cells derived from the adult SVZ [198] and Wnt-7a 
and Wnt-7b increased formation of neurospheres [199]. Depletion of Wnt-3a 
resulted in decreased proliferation of cells at the caudomedial margin which in 
turn led to poor hippocampal development [200] while depletion of Wnt-1 
affected NSC proliferation in the developing midbrain and hindbrain and 
resulted in abnormalities in these regions [201].  
Wnt proteins also promote neuronal differentiation. Wnt-3 has been 
shown to induce neurogenesis of hippocampal NSCs in vitro while inhibition 
of Wnt signalling blocks neurogenesis in vivo [202]. Higher Wnt-3a activity 
stimulates neuronal differentiation in the neocortex [203] and in neurospheres 
derived from embryonic telencephalon [204]. It has been shown that the Wnt 
signalling pathway stimulates neuronal differentiation by expression of the 




Figure 1.7 Wnt signalling pathway. 
(A) In the absence of Wnt, the multiprotein complex containing Axin enables 
hyperphosphorylation of β-catenin, which is a target for degradation by 
ubiquitination. (B) In the presence of Wnt, the Wnt ligand binds to the 
Frizzled/LRP-5/6 receptor complex which destabilizes the destruction 
complex. This leads to hypophosphorylation and stabilization of β-catenin. 
The stabilized β-catenin then interacts with TCF/LEF proteins in the nucleus 







1.9.3 Sonic hedgehog signalling and related factors 
Sonic hedgehog (Shh) signalling is another pathway important in NSC 
biology. In mammals, three types of hedgehog signalling exist, namely the 
Shh, Indian hedgehog and Desert hedgehog pathways. Among these, the Shh 
pathway is the most extensively studied. The Shh pathway begins when the 
ligand Shh binds to its receptor, Patched1, a membrane-bound protein. 
Smoothened, another membrane protein, is usually inhibited by Patched1. 
Upon binding of Shh to Patched1, this inhibition is removed and Smoothened 
is activated. Activation of Smoothened eventually leads to the activation of Gli 
transcription factors and thus, expression of Gli- target genes (Figure 1.8). The 
sequence of events linking activation of Smoothened and activation of Gli 
factors is still poorly understood. The Shh pathway plays a key role in CNS 
development as it is involved in NSC/NP proliferation in various brain regions 
such as the neocortex and cerebellum at both late embryonic and postnatal 
stages [206-208]. To mediate these effects, the Gli transcription factors 
function as central players in the Shh signalling pathway. 
Gli1. Overexpression of Gli1 led to bigger brains and expansions in the 
NSC/NP population and seems to be strongly correlated with higher 
neurosphere formation [209]. On the other hand, knockdown of Gli1 resulted 
in reduced cell proliferation and neurosphere formation [210]. These findings 
indicate that Gli1 is crucial for NSC/NP proliferation. Interestingly, Gli1-null 
mutants appear normal [211] and seem to maintain the NSC population [210], 
suggesting that Gli1 is not essential for NSC self-renewal and multipotency.  
Gli2 and Gli3. Knockdown of Gli2 blocked NSC/NP proliferation and 
reduced expression of NSC markers such as Sox2 and CD133 both in vivo and 
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in vitro [212]. Gli2 and Gli3-null mutants do not survive at birth and show 
reduced VZ/SVZ and cortical size [213, 214]. When cultured in vitro, these 
mutant cells show decreased proliferation and neurosphere formation [215]. 
These observations indicate that Gli2 and Gli3 promote NSC/NP proliferation. 
In addition, Gli2 and Gli3-null mutant cells could not be passaged more than 
four times and are not multipotent, suggesting that Gli2 and Gli3 are essential 





Figure 1.8 Sonic hedgehog signalling pathway. 
In the absence of Shh ligand, the Ptch receptor suppresses the activity of Smo. 
The cytoplasmic proteins Fused and SUFU prevent Gli from entering the 
nucleus. In the presence of Shh ligand, Shh binds to Ptch receptor which 
removes the inhibition of Ptch on Smo. Activated Smo eventually removes the 
inhibition of Fused and SUFU on Gli which is now free to enter the nucleus. 
Gli then leads to the transcription of target genes important for NSC self-
renewal and proliferation. Abbreviations: Shh, Sonic hedgehog; Ptch, Patched; 










1.10 Single-cell mRNA profiling 
The behavior and fate of a cell is determined by its gene regulatory 
network. One of the ways to investigate gene regulatory networks is to 
perform mRNA profiling which evaluates the expression of genes of interest. 
mRNA profiling usually comprises of two important steps - reverse 
transcription polymerase chain reaction (RT-PCR) where cDNA is generated 
from mRNA and qPCR (quantitative polymerase chain reaction) where the 
amount of cDNA is measured. Conventional methods of RT-PCR and qPCR 
use total RNA extracted from a population of cells. However, using a 
population of cells as starting material leads to a few disadvantages. First, total 
RNA content of mammalian cells lies between 20 to 40pg of which the mRNA 
constitutes only 0.5 to 1.0pg. Usually thousands to millions of cells are 
required to provide sufficient RNA. This poses a limitation when studying rare 
cell populations where it is challenging to collect large numbers of cells. 
Second, when the cell population of interest is heterogeneous, gene expression 
readouts are often an average of the population. Thus cell to cell variability in 
gene expression is masked which could provide crucial information about 
gene regulation in different cells. Third, the distribution of transcripts among 
cells is also difficult to evaluate based on average gene expression readouts in 
a population. It was then realized that profiling the mRNA of single cells 
rather than a population of cells would help overcome these limitations. This 
prompted the development of single-cell mRNA profiling methods. 
Single-cell mRNA profiling involves a series of steps including 
collection of single cells, cell lysis, reverse transcription, cDNA amplification 
and qPCR. The earliest protocol for single-cell mRNA profiling dates back to 
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the late 1980s where Rapopolee and colleagues designed a protocol known as 
“single-cell mRNA phenotyping” [216, 217]. In this method, more than 10 
genes could be analyzed in small cell samples including single cells. Briefly, 
total RNA is isolated and cDNA is generated by RT-PCR using an oligo dT 
primer and subsequent PCR is performed on aliquots of the cDNA for each 
gene [217]. At least 100 mRNA molecules and three-fold difference in mRNA 
quantity could be detected by single-cell mRNA phenotyping [217]. Further 
developments in single-cell mRNA profiling enabled the analysis of multiple 
genes in one PCR reaction (multiplex analysis). As many as seven separate 
genes have been analyzed using cDNA from single Purkinje neurons and 
Bergman glial cells [218]. Most commonly, relative expression of genes is 
analyzed by comparing the intensity of bands after PCR [219]. For absolute 
mRNA quantification, competitor RNA is added in known amounts to the RT-
PCR reaction [220, 221]. 
Further developments were made in the 1990s to allow one to quantify 
all or at least the majority of genes in single cells. In particular, global 
amplification protocols were developed. A classic example of such a method 
involves the use of an oligo dT primer incorporated with an RNA polymerase 
promoter sequence [222, 223]. This primer and RNA polymerase are used to 
generate RNA copies of each cDNA molecule after reverse transcription. 
Other global amplification methods such as the Belyavsky [224], PolyAPCR 
and TPEA (3 prime end amplification) method [225] were developed 
independently where the mRNA poly(A) tail is used as the initial priming site. 
A review by Gerard Brady provides a comprehensive description on how these 
protocols were developed and work [226]. 
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While earlier protocols focused on optimizing the reverse transcription 
and amplification steps to improve sensitivity, more recent protocols also 
ensured development of other steps such as isolation of single cells to ensure 
good quality data. Stahlberg and Bengtsson provide a detailed review on the 
various protocols available for each step in single-cell mRNA profiling [227]. 
Currently, there are three commonly used methods of isolating single cells, 
each with their own advantages and disadvantages. The first method is to 
physically pick out individual cells under a microscope using techniques such 
as mouth pipetting. Mouth pipetting is usually used on cells cultured in 
suspension in scenarios where there is a lack of surface markers for the desired 
cell or when an imaging-related parameter marks the cell of interest. Briefly, a 
glass pipette is fixed on the microscope and a tube runs from the pipette to the 
mouth of the researcher. The researcher then draws the cell into the pipette and 
releases the cell into the appropriate collection vessel. This may require long 
hours and could be technically challenging. Long hours outside the incubator 
could result in mRNA degradation unless the microscope system is fitted with 
a chamber where temperature, humidity and CO2 concentration could be 
controlled. It is also crucial to freeze the cells immediately after picking to 
minimize mRNA degradation. 
The second method for isolating single cells is FACS. FACS is 
suitable for cells which can be prepared in suspension. FACS also enables one 
to isolate rare cell populations of interest which are marked by expression of 
specific surface molecules or fluorescence reporters. Advances in FACS such 
as use of two or more fluorescence labels facilitate the isolation process. It is 
crucial to ensure that the FACS instruments are calibrated with precision to 
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ensure that each individual cell is sorted into the middle of the well of the PCR 
plate or collection tube. During FACS, the cells experience pressure and 
changes in shape and morphology. Whether these changes have any effect on 
the integrity of the mRNA is not clear. The time taken for sorting is also 
crucial as long sorting time may lead to mRNA degradation. Optimization of 
FACS parameters such as the sheath pressure and flow rate and freezing the 
cells immediately after sorting are ways to ensure mRNA quality is maximally 
preserved.  
The third method of isolating single cells is microdissection (reviewed 
in [228]). FACS does not facilitate isolation of cells from solid tissues such as 
those found in tumors or those mounted on slides. Under such circumstances, 
microdissection could “cut” out the individual cell from the tissue. In 
particular, the laser-assisted microdissection involving the laser “catapult” 
[229, 230] and laser “capture” [231, 232] techniques is commonly used. In the 
catapult technique, a UV laser is used to cut out a boundary surrounding the 
cell. The laser is then positioned beneath the cell and “catapults” the cell into a 
collecting cap. In the capture technique, infrared laser is focused on the cell in 
a tissue positioned between a plastic film and glass slide. The laser melts the 
plastic film at the cell of interest and when the laser is switched off, the plastic 
solidifies and attaches to the cell. The cell is then “captured” or removed. 
Progressive developments over the last three decades have now 
established a number of platforms for single-cell mRNA profiling, each 
customized to fulfill various research aims. Some platforms are high- 
throughput and analyze expression of hundreds or thousands of genes or even 
the whole genome. For instance, special microarray platforms have been used 
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to profile thousands of genes in single hippocampal CA1 and CA3 neurons 
[233, 234]. For more focused studies, other platforms are available which 
analyze expression of a selected panel of genes. An excellent example of such 
a platform was developed by Fluidigm. Using the Fluidigm arrays, expression 
of 48 genes in 48 single cells or 96 genes in 96 single cells can be profiled in 
one PCR run.  
New protocols and instruments are constantly being developed to 
improve the sensitivity, accuracy and workflow of single-cell mRNA 
profiling. For instance, the C1™ Single-Cell Auto Prep IFC from Fluidigm is 
a system that integrates collection of single cells, lysis and the RT reactions all 
in one instrument allowing for a more efficient workflow. However, it is 
worthy to note that efficient protocols and instruments have to be coupled with 
good laboratory practices to obtain good quality single-cell mRNA data. 
Performing reactions under RNase-free conditions and proper handling and 
storage of reagents are examples of good laboratory practices. 
1.11 Aims of thesis 
NSCs are cells of the CNS which have two important characteristics – 
ability to self-renew and differentiate into the three major neural lineages. In 
the early 1990s, Reynolds and Weiss developed the neurosphere culture 
system where NSCs and NPs were propagated as free-floating three-
dimensional spheroid structures. In this system, NSCs and some NPs have the 
ability to form neurospheres.  
Despite being used to culture and investigate NSCs and NPs in vitro 
for over 20 years, we still do not have a clear understanding of the cell types 
present within the neurosphere culture system. In addition, the identity of 
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neurosphere-forming cells (NFCs) remains unknown. Furthermore due to the 
lack of specific markers, NSCs have not been definitely identified in 
neurospheres and it remains a challenge to distinguish NSCs from NPs in 
vitro. This has also led to a limited understanding of the genes and signalling 
pathways which govern NSC biology. Therefore, the main aims of this thesis 
are to: 
(i) Determine the progenitor subclasses present within 
neurospheres 
(ii) Identify and characterize NFCs and their mRNA profile 
(iii) Identify and characterize NSCs and their mRNA profile 
(iv) Distinguish NSCs from NPs in vitro 
(v) Identify candidate genes and signalling pathways important for 
NSCs 
Advances in single-cell mRNA profiling have enabled the 
development of platforms to study the expression of genes in individual cells 
in a sensitive and efficient manner. Single-cell mRNA profiling allows one to 
distinguish the different cell types in heterogeneous culture systems. Since 
neurospheres are a heterogeneous mix of cells, I selected single-cell mRNA 
profiling as the choice of method to meet the above stated aims. 
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2 MATERIALS AND METHODS  
2.1 Cell culture 
2.1.1 Isolation and culturing of neural stem cells/neural progenitors 
All animal experiments were approved by the Biomedical Research 
Council Singapore and Institutional Animal Care and Use Committee in 
accordance with national guidelines. NSCs and NPs from E14.5 C57BL/6 
mice were isolated as previously described with some modifications [235]. 
Pregnant C57BL/6 mice were sacrificed by cervical dislocation and the 
embryos were removed and placed in ice-cold Hanks’ balanced salt solution. 
Cerebral cortices of the embryos were excised and triturated into single-cell 
suspension. Dissociated cells were seeded at 2x105 cells/ml in 10 cm culture 
dishes (NUNC) in NSC growth medium [Dulbecco’s Modified Eagle’s 
Medium (DMEM)/nutrient mixture F-12 (1:1) medium (Invitrogen), B27 
supplement (Invitrogen), 20ng/ml EGF (Peprotech), 10ng/ml bFGF 
(Peprotech) and 1% penicillin/streptomycin (Invitrogen)] to grow as 
neurospheres at 37oC in a 5% CO2 atmosphere in a humidified incubator for 
four days. 
2.1.2 Cryopreservation and thawing of neural stem cells/neural 
progenitors 
After propagation for four days, neurospheres were chemically 
dissociated with 0.05N sodium hydroxide (Sigma) and neutralized with 0.05N 
hydrochloric acid (Sigma). Dissociated cells were seeded at 2x104 cells/ml and 
propagated for two days and then cryopreserved as passage 2 neurospheres in 
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NSC growth medium containing 10% DMSO (Sigma) at -80°C liquid 
nitrogen. 
 To thaw NSCs/NPs, 1ml of cryopreserved passage 2 neurospheres was 
transferred from -80°C liquid nitrogen to 37°C water bath. 5ml of NSC growth 
medium was added and the neurospheres were centrifuged at 1000rpm for one 
minute. The supernatant was then removed and the neurospheres were 
resuspended in 10ml of fresh NSC growth medium and cultured in a 10 cm 
culture dish (NUNC) at 37°C, 5% CO2. 
2.1.3 Passaging and propagation of neurospheres 
Neurospheres were centrifuged in a 15ml falcon tube at 1000rpm for 
one minute and supernatant was removed till the last 1ml of cell mixture. 1ml 
of 0.05N sodium hydroxide (Sigma) was added to the neurospheres and mixed 
by pipetting up and down. The cells were incubated at room temperature for 7 
minutes for dissociation to occur. 1ml of 0.05N hydrochloric acid (Sigma) was 
then added for neutralization. The number of viable cells was counted using 
Trypan Blue exclusion assay on a haemocytometer. The cells were then 
seeded in NSC growth medium at 2x104 cells/ml in 10 cm culture dishes and 
propagated at 37°C, 5% CO2. Neurospheres were subsequently passaged every 
5-7 days.  
For experiments requiring CSPG and ApoE, CSPG (Sigma) and/or 
ApoE (Merck Biosciences) were added to the NSC growth medium at final 
concentrations of 50µg/ml and 50nM respectively. These concentrations are 
optimal for neurosphere formation [120, 121]. 
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2.1.4 Isolation and culturing of Hes1-GFP neural stem cells/neural 
progenitors 
For Hes1-GFP NSCs/NPs, cerebral cortices of C57BL/6 Hes1-GFP 
transgenic mouse embryos were excised and triturated into single cells. Single 
cells were seeded in NSC growth medium and incubated at 37°C, 5% CO2 to 
grow as neurospheres. These primary neurospheres were directly used for 
experiments. Neurospheres were passaged as described in section 3.1.3 when 
required. 
2.2 Single-cell mRNA profiling of 48 genes and data processing 
2.2.1 Sorting and lysis of single cells  
Each of the 48 TaqMan assays (20x, Applied Biosystems) was added 
to a final concentration of 0.2x for each assay to form a TaqMan assay pool. 
Single cells from dissociated neurospheres were sorted by FACS directly into 
10µl of RT-PreAmp Master Mix [5µl CellsDirect 2x Reaction Mix 
(Invitrogen), 2.5µl 0.2x Assay pool, 0.5µl SuperScript® III RT/Platinum® Taq 
mix (Invitrogen) and 2µl TE buffer (Qiagen)]. Cells were frozen at -80ºC and 
thawed to induce lysis. For LeX+ve CD93+ve Phbrt (Phase bright)+ve cells, 
LeX+ve CD93+ve cells were sorted by FACS and allowed to recover at 37°C for 
at least two hours. Single Phbrt+ve (>240 grey values) cells within this 
population were then manually transferred using a micropipette into 4µl of 
NSC growth medium under the Olympus IX81 inverted motorised 




2.2.2 Sequence-specific reverse transcription and cDNA pre-
amplification  
Sequence-specific reverse transcription (50°C for 20 minutes) and 
reverse transcriptase inactivation (95°C for 2 minutes) were performed to 
generate cDNAs of the 48 genes. After which, sequence-specific pre-
amplification (18 cycles at 95°C for 15 seconds and 60°C for 4 minutes) was 
performed. All reactions were carried out in a PCR thermal cycler (Biorad). 
The pre-amplified cDNA was diluted five-fold with nuclease-free water 
(Promega) and stored at -80°C. For LeX+ve CD93+ve Phbrt+ve cells, pre-
amplified cDNA was diluted two-fold.  
2.2.3 Single-cell real-time PCR  
Real-time assay mix was prepared for each of the 48 genes by adding 
2.5µl of the specific TaqMan assay (20x, Applied Biosystems) to 2.5µl of 2x 
DA assay loading reagent (Fluidigm). Real-time sample mix was prepared by 
adding 3.2µl of specific cDNA to 0.35µl of DA sample loading reagent 
(Fluidigm) and 3.5µl of TaqMan® Universal PCR Master Mix (Applied 
Biosystems). Single-cell real-time PCR was performed according to 
manufacturer’s instructions (Fluidigm). Briefly, control line fluid (Fluidigm) 
was introduced into the BioMark™ 48.48 dynamic array (Fluidigm) and 
primed in the integrated fluidic circuit controller (Fluidigm). 5µl of each real-
time assay mix and real-time sample mix was added into the respective wells 
in the array and loaded into the reaction chambers of the array using the 
integrated fluidic circuit controller. The array was then transferred to the 
BioMark™ System (Fluidigm) and real-time PCR was performed.  
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The real-time PCR began with an amplification erase phase at 50°C for 
2 minutes, followed by a hot start phase at 95°C for 10 minutes to activate the 
Taq polymerase. The cDNA was then denatured at 95°C for 15 seconds and 
annealed at 60°C for 1 minute. The denaturation and annealing phase were 
repeated for 40 cycles and Ct values were collected using the BioMark™ data 
collection software (Fluidigm). Ct values were then analyzed using the 
BioMark™ real-time PCR analysis software (Fluidigm) and exported to 
Microsoft Excel. For cells collected by FACS, Ct value for the endogenous 
control β-actin between 15 and 25 was considered for analysis. For cells 
collected by manual picking, β-actin Ct values between 9 and 16 were 
considered. Ct values for a specific cell were normalised to the endogenous 
control by subtracting the Ct value of β-actin for the same cell. The assumed 
baseline Ct value is 31. Where populations or clusters are compared, the 
normalised Ct value (ΔCt) for each cell in a population was added and 
averaged to obtain the average ΔCt value.  The term 2-ΔΔCt was used to 
determine relative expression of genes between two populations or clusters. 


































Figure 2.1 Workflow for single-cell mRNA profiling. 
E14.5 mouse neurospheres were dissociated into single cells and collected by 
FACS or manual picking. Each cell was lysed before reverse transcription and 
pre-amplification of cDNA were performed. This was followed by real-time 
PCR on BioMark™ 48.48 array to analyze the expression of 48 selected 
genes. Abbreviations: FACS, fluorescence activated cell sorting; PCR, 
polymerase chain reaction. Reproduced and modified with permission from 
my published paper Narayanan et al., 2012, Figure 1 [236]. 
Cell lysis, reverse transcription 
and cDNA pre-amplification for 48 genes 
E14.5 mouse neurospheres 
Single cells 
Dissociation 
FACS or manual picking 
to collect single cells 




2.2.4 Clustering of cells based on mRNA profile 
Cells were clustered using non-metric multi-dimensional scaling 
(nMDS) and Model- Based Clustering (Mclust). After dimension reduction by 
nMDS, Mclust was performed partitioning cells into clusters. The R- packages 
neatmap and mclust were used for performing nMDS and Mclust respectively 
(for information on nMDS see [237, 238]). Expression bar plots were 
generated using R- package in TreeView software. For heatmaps, ∆Ct values 
for each gene were normalized with the median value for that gene. The 
median- normalized ∆Ct values were used to construct the heatmaps using 
MultiExperiment Viewer (MeV) version 4.8. 
2.2.5 Violin plots 
Violin plots are a type of box plots with additional information on 
probability density at different values of the data. Violin plots were derived for 
each gene involved in the single-cell mRNA profiling using R- package in 
TreeView software. From the Ct values for a specific gene, the interquartile 
range is represented by the values along the y-axis and the probability density 
is represented along the x-axis, giving rise to a unimodal or multimodal plot. 
A unimodal distribution suggests minimal variation of gene expression among 
the cells while a multimodal distribution suggests subpopulations of cells with 
differing gene expression. The plot is then reflected along a line parallel to the 




2.2.6 Distribution curve reflecting likelihood of obtaining specific 
clusters 
Single-cell mRNA data from all cells in the two populations involved 
in the relevant analysis were pooled and the specific number of cells in the 
cluster of interest was randomly selected. Among the randomly selected cells, 
the ratio of the number of cells belonging to one population to the number of 
cells belonging to the other population was calculated. This procedure was 
repeated 1000 times to construct the distribution curve.  
2.3 FACS 
2.3.1 Preparation of cells for FACS 
Dissociated cells were centrifuged at 1000rpm for 1 minute in a 15ml 
or 50ml falcon tube and supernatant was removed. The cells were resuspended 
in 100µl phosphate buffered saline (PBS) and transferred to a 1.5ml 
microcentrifuge tube. The cells were then washed once with 100µl PBS. When 
staining of cell surface proteins is required, the cells were subsequently 
blocked with 100µl of 3% bovine serum albumin (Sigma) for 15 minutes at 
room temperature. After blocking, the cells were centrifuged in a tabletop 
microcentrifuge for 1 minute and supernatant was removed. The cells were 
resuspended in 90µl of PBS and stained with 10µl of selected antibodies for 
15 minutes at room temperature in the dark. The selected antibodies used are 
against mouse LeX [fluorescein isothiocyanate (FITC) conjugated, BD 
Biosciences], mouse CD93 [phycoerythrin (PE) conjugated, R&D Systems], 
mouse Notch1 [allophycocyanin (APC) conjugated, R&D systems], mouse 
Dll1 (APC conjugated, R&D systems), mouse EGFR (APC conjugated, R&D 
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systems), mouse CXCR4 (PE/Cy7 conjugated, Biolegend). After which, the 
cells were centrifuged in a tabletop microcentrifuge for 1 minute and 
supernatant was removed. The cells were then resuspended in PBS and filtered 
through a 35µm nylon mesh, collected in a 5ml polystyrene round-bottom tube 
(BD Falcon™) and kept in ice. Unstained cells were prepared in parallel.  
2.3.2 Cell sorting 
Sorting was performed on a UV FACSAria flow cytometer (BD 
Biosciences) using FACSDiva software (BD Biosciences). Before sorting, the 
nozzle, sheath, and sample lines were sterilized with 70% ethanol for 15 
minutes and washed with sterile water to remove decontaminants. A 100μm 
ceramic nozzle (BD Biosciences), sheath pressure of 20-25 PSI and an 
acquisition rate of 1,000 events per second were used. Dead cells and debris 
were excluded based on forward scatter (FSC) and side scatter (SSC). 
Aggregated cells were removed based on SSC-W/SSC-H and FSC-W/FSC-H 
gatings. Fluorescence was determined by analysis and gating against 
appropriate controls prepared in parallel. Cell populations of interest were 
sorted at required cell densities into NSC growth medium for neurosphere 
formation or into RT-PreAmp Master Mix for single-cell mRNA profiling. 
2.4 Neurosphere formation assay 
Cells were plated at low density (1x103 cells/ml in a 24-well plate) or 
at clonal density (1 cell/well in a 96-well plate) and cultured for 7 days at 
37°C, 5% CO2 to form neurospheres. After 7 days, the neurospheres were 
stained with Cell Tracker Green (Invitrogen) at 500nM final concentration for 
imaging purposes. For low density cultures, the wells were imaged on a Zeiss 
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Axiovert 200M or Olympus IX81 inverted motorised microscope with a 4x 
lens using the screen acquisition tool in Metamorph software. The neurosphere 
number and size were automatically quantified using a custom designed 
analysis tool in Metamorph. For clonal density cultures, the neurospheres were 
scored manually. The NFU was calculated as the number of neurospheres 
formed per 100 cells plated.  
For secondary neurosphere formation, primary neurospheres were 
collected, dissociated, replated at low density (1x103 cells/ml) and grown for 7 
days. The number of secondary neurospheres was scored automatically as 
described above.  
2.5 Neurosphere differentiation 
Individual neurospheres were transferred to each well of a 50-well 
chambered coverslip (Sigma) coated with poly-L-lysine (PLL) (0.01%; 
Sigma) and laminin (10µg/ml; Invitrogen) and incubated at 37°C overnight for 
attachment. In parallel, 3x106 dissociated cells from neurospheres were plated 
in differentiation medium [DMEM/F-12 (1:1) medium (Invitrogen), B27 
supplement (Invitrogen), 0.5% fetal bovine serum (Invitrogen) and 1% 
penicillin/streptomycin (Invitrogen)] in a 10 cm culture dish (NUNC) coated 
with PLL and laminin and incubated at 37°C overnight. The next day, the 50-
well coverslip with the attached single neurospheres was inverted onto the 10 
cm dish containing differentiating cells. Care was taken to ensure that 
neurospheres on the coverslip did not contact the cells in the 10 cm dish. 
Differentiating cells from the 10 cm dish secrete neurotrophic factors into the 
conditioned medium which promote differentiation of the single neurospheres 
on the coverslip. In the absence of these neurotrophic factors, the single 
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neurospheres plated alone would not survive or would only give rise to 
astrocytes. The single neurospheres were differentiated for four days at 37°C, 
5% CO2. 
2.6 Immunocytochemistry 
2.6.1 Immunocytochemistry of differentiated neurospheres  
Differentiated neurospheres were washed twice with PBS and fixed in 
4% paraformaldehyde for 20 minutes. The neurospheres were then washed 
thrice with PBS and blocked with 3% BSA (Sigma) for 30 minutes. After 
blocking, the neurospheres were stained with mouse anti-O4 IgM (1:300; 
Chemicon) for two hours. Following which the neurospheres were washed 
with PBS and stained with secondary antibody Alexa Fluor 488 goat anti-
mouse IgM (1:500; Invitrogen) for one hour. The neurospheres were washed 
with PBS and permeabilized with 0.5% Triton X- 100 for 20 minutes. 
Subsequently, the neurospheres were washed with PBS and stained with 
mouse anti-βIII-tubulin (Tuj1) IgG2a (1:500; Covance) and rabbit anti-GFAP 
IgG (1:1000; Dako) for two hours. After which the neurospheres were washed 
with PBS and stained with the secondary antibodies Alexa Fluor 594 goat anti-
mouse IgG2a (1:500; Invitrogen) and Alexa Fluor 647 donkey anti-rabbit IgG 
(1:500; Invitrogen) for an hour. Next, the neurospheres were washed with 
PBS, stained with 4’,6’-diamidino-2-phenylindole dihydrochloride (DAPI; 
Invitrogen) for two minutes and then washed again once with PBS and twice 
with water. The coverslip was then mounted on a glass slide using 
Hydromount (National Diagnostics) and allowed to dry overnight at room 
temperature. Images were captured using the Olympus point scanning FV-
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1000 confocal microscope and the number of unipotent, bipotent and tripotent 
neurospheres was scored.  
2.6.2 Phosphacan immunocytochemistry 
Coverslips were coated with PLL and FSC/SSC high and FSC/SSC low 
cells were added and left for at least an hour to adhere to the coverslips. The 
cells were stained with mouse anti-phosphacan antibody (1:10; Millipore) 
followed by secondary staining with Alexa Fluor 488 goat anti-mouse 
antibody (1:500; Invitrogen). Nuclei were counterstained with DAPI 
(Invitrogen). Images were taken using Zeiss Axiovision microscope and 
fluorescence intensity was analysed using Metamorph software. 
2.7 Timelapse for cell size to neurosphere formation correlation 
Dissociated cells were plated at low density (1x103 cells/ml) in a 96-
well plate (NUNC). The cells were imaged and their cell size determined on a 
Zeiss Axiovert 200M microscope (Zeiss) using DIC imaging. The system 
consists of an enclosed Pecon XL3 incubator for focus stability. Cells were 
maintained at 37°C, 5% CO2 using a Pecon heating insert P with the required 
level of humidity. A Marzhauser motorized XY stage allows for automated 
imaging at specific sites. Images were taken every two hours at 20x 
magnification using a CoolSnap HQ CCD camera over five days to follow 
neurosphere formation. 
2.8 Statistical analysis 
Results are presented as mean ± standard deviation (SD) unless 
otherwise stated. Two-tailed student’s T- test was used as test for significance 
where means of two groups were compared. One-way ANOVA with post-hoc 
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comparisons using Bonferroni test was used as test for significance where 
means of more than two groups were compared. P- values in the figures are 
denoted as *P≤0.05, **P≤0.01, ***P≤0.001. 
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3 RESULTS: PROGENITOR SUBCLASSES AND NEUROSPHERE –
FORMING CELLS IN NEUROSPHERES  
3.1 Single-cell mRNA profiling identifies three cell populations in 
neurospheres – early, intermediate and late neural progenitors 
To determine the different progenitor subclasses in embryonic mouse 
neurospheres, single-cell mRNA profiling of 48 genes closely associated with 
NSCs was performed (Table 3.1). The term “progenitor subclasses” is used 
here to define both NSCs and NPs as no distinction between NSCs and NPs is 
made at this juncture. These genes include those from major signalling 
pathways (Notch, Wnt, Shh signalling) and classes of genes such as POU 
factors and basic helix-loop-helix (bHLH) factors. The 48 genes were selected 
based on their satisfaction of any of the following four criteria; (i) known NSC 
markers, (ii) genes with known functions in NSCs, (iii) genes involved in 
important signaling pathways in NSCs such as the Notch, Shh and Wnt 
pathways, (iv) genes involved in neurodevelopment but not well-studied in the 
context of NSCs. 187 cells from passage 2 neurospheres were profiled and 
clustered using nMDS and Mclust. Single cells were collected by FACS as 
shown in Figure 3.1. These cells are termed as unsorted cells since they were 
not sorted according to any marker. Three cell clusters were delineated – US 
(unsorted) 1, US2 and US3 (Figure 3.2). The percentage of total cells in 
clusters US1, US2 and US3 were 9.7%, 65.6% and 24.7% respectively.  
I sought the identity of the three clusters based on their mRNA 
profiles. A heatmap was constructed from the expression data to visually 
present the mRNA profile of each cluster (Figure 3.3). Bar plots showing the 
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genes which were significantly expressed at a higher or lower level in a 
specific cluster compared to the other two clusters combined were constructed 
from the expression data (Figure 3.4). 
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Table 3.1 Genes selected for single-cell mRNA profiling  
 
 
Gene abbreviation Full gene name NCBI accession number TaqMan ID* 
Sox5 SRY-box containing gene5 NM_011444.2 Mm00488381_m1 
Sox6 SRY-box containing gene6 NM_001025559.2 Mm00488393_m1 
Sox9 SRY-box containing gene9 NM_011448.4 Mm00448840_m1 
Hes1 Hairy and enhancer of split1 NM_008235.2 Mm01342805_m1 
Hes5 Hairy and enhancer of split5 NM_010419.4 Mm00439311_g1 
Hes6 Hairy and enhancer of split6 NM_019479.3 Mm00517097_g1 
Notch1 Notch gene homolog1 NM_008714.3 Mm00435249_m1 
Jag1 Jagged1 NM_013822.5 Mm00496902_m1 
Dll1 Delta-like1 NM_007865.3 Mm00432841_m1 
Dll3ǂ Delta-like3 NM_007866.2 Mm00432854_m1 
CBF1 Recombination signal binding protein for immunoglobulin kappa J region NM_009035.4 Mm00770450_m1 
POU3F1 POU domain, class 3, transcription factor 1 NM_011141.2 Mm00843534_s1 
POU3F2 POU domain, class 3, transcription factor 2 NM_008899.1 Mm00843777_s1 
POU3F3 POU domain, class 3, transcription factor 3 NM_008900.2 Mm00843792_s1 
POU3F4 POU domain, class 3, transcription factor 4 NM_008901.1 Mm00447171_s1 
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β-catenin Cadherin associated protein, beta1 NM_001165902.1 Mm01350394_m1 
Olig1 Oligodendrocyte transcription factor1 NM_016968.4 Mm00497537_s1 
Olig2ǂ Oligodendrocyte transcription factor2 NM_016967.2 Mm01210556_m1 
bHLHB2 Basic helix-loop-helix family, member e40 NM_016967.2 Mm00478593_m1 
FGFR1 Fibroblast growth factor receptor1 NM_001079908.1 Mm01215485_g1 
FGFR2 Fibroblast growth factor receptor 2 NM_010207.2 Mm00438941_m1 
EGFR Epidermal growth factor receptor NM_007912.4 Mm01187858_m1 
GLAST Glutamate aspartate transporter NM_148938.3 Mm00600697_m1 
BLBP Brain lipid binding protein NM_021272.3 Mm00445225_m1 
Prom1 Prominin1 NM_001163577.1 Mm00477115_m1 
Bysl Bystin-like NM_016859.3 Mm00479473_m1 
Msi1 Musashi1 NM_008629.1 Mm00485224_m1 
c-kit c-kit oncogene NM_001122733.1 Mm00445212_m1 
Eng Endoglin NM_001146348.1 Mm03023983_m1 
Nes Nestin NM_016701.3 Mm00450205_m1 
Gli1ǂ GLI-Kruppel family member1 NM_010296.2 Mm00494645_m1 
Gli2 GLI-Kruppel family member2 NM_001081125.1 Mm01293117_m1 
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Pax6 Paired box gene6 NM_013627.4 Mm00443081_m1 
Myc Myelocytomatosis oncogene NM_001177352.1 Mm00487804_m1 
Bmi1 Bmi1 polycomb ring finger oncogene NM_007552.4 Mm00776122_gH 
REST RE1-silencing transcription factor NM_011263.2 Mm00803268_m1 
FoxG1 Forkhead box G1 NM_001160112.1 Mm02059886_s1 
NFIA Nuclear factor I/A NM_001122952.1 Mm00447981_m1 
NFIB Nuclear factor I/B NM_001113209.1 Mm00500784_m1 
NFIX Nuclear factor I/X NM_001081982.1 Mm00477796_m1 
MamI2 Mastermind like2 NM_001013813.3 Mm00620617_m1 
Klf12 Kruppel-like factor12 NM_010636.3 Mm00516098_m1 
Tead1 TEA domain family member1 NM_001166584.1 Mm00493503_m1 
Tead2 TEA domain family member 2 NM_011565.2 Mm00449004_m1 
Ybx1 Y box protein 1 NM_011732.2 Mm00850878_g1 
Sub1 SUB1 homologue NM_011294.3 Mm00726782_s1 
HMGA2 High mobility group AT-hook 2 NM_010441.2 Mm00780304_sH 
MashIǂǂ Achaete-scute complex homolog 1 (Drosophila) NM_008553.4 Mm03058063_m1 
Myt1Lǂǂ Myelin transcription factor 1-like  NM_001093775.1 Mm00485408_m1 
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Sox2ǂǂ SRY-box containing gene2 NM_011443.3 Mm03053810_s1 
β-actin Beta-actin NM_007393.3 Mm01205647_g1 
 
* All TaqMan assays are not intron spanning. 
ǂ These genes are included in single-cell mRNA profiling for unsorted cells and FSC/SSC-sorted cells but not for LeX/CD93 and LeX/CD93/Phbrt sorted cells. 
ǂǂ These genes are included in single-cell mRNA profiling for LeX/CD93 and LeX/CD93/Phbrt sorted cells but not for unsorted and FSC/SSC-sorted cells. 
Table is reproduced and modified with permission from my published paper Narayanan et al., 2012, Table S1 [236]. 



























Figure 3.1 FACS gating for unsorted cells. 
(A) Dead cells and debris were excluded by gating only the live cells based on FSC/SSC 
parameters. Within the live cells, only singlets were included by performing doublet 
discrimination using (B) SSC-W/SSC-H and (C) FSC-W/FSC-H parameters. Abbreviations: 








Figure 3.2 Single-cell mRNA profiling of unsorted neurosphere cells.  
nMDS was used to compress 48-dimensional mRNA profiling data from 187 
passage 2 unsorted neurosphere cells to two dimensions. Axes are labeled as 
nMDS_1 and nMDS_2 for the two dimensions. Cells were then clustered by 
Mclust based on the mRNA profile of 48 genes. Three clusters were observed 
– US1, US2 and US3. Abbreviations: nMDS, non-metric multi-dimensional 
scaling. This work was done in collaboration with Anuradha Poonepalli 
(Institute of Medical Biology, Singapore) and Chen Jinmiao (Singapore 
Immunology Network, Singapore). Reproduced with permission from my 





Figure 3.3 Heatmap showing the mRNA profile of clusters US1, US2 and US3.  
Each row and column represents one cell and one gene respectively. Genes under the P<0.05 
section are genes showing a statistically significant change in expression in cluster US1 
compared to clusters US2 and US3 combined. Red and green colours represent high and low 
expression respectively. This work was done in collaboration with Anuradha Poonepalli 
(Institute of Medical Biology, Singapore) and Chen Jinmiao (Singapore Immunology 
Network, Singapore. Reproduced with permission from my published paper Narayanan et al., 





















Figure 3.4 Genes with significant change in expression in clusters 
US1, US2 and US3. 
Log2 fold change in gene expression for genes that show significant 
change in expression (P<0.05) in a cluster in comparison with the 
remaining clusters combined. Panels (A), (B) and (C) show bar plots 
for clusters US1, US2 and US3 respectively. This work was done in 
collaboration with Anuradha Poonepalli (Institute of Medical 
Biology, Singapore) and Chen Jinmiao (Singapore Immunology 
Network, Singapore). Reproduced with permission from my 





Previously, Kawaguchi et al. performed single-cell mRNA profiling to 
investigate the different progenitor subclasses present in vivo in the embryonic 
mouse brain [239]. They identified three progenitor groups - apical, young 
basal and basal progenitors. The apical and young basal progenitors are 
located in the VZ and are at an early developmental stage. Their data showed 
that the apical progenitors on average had high expression of NSC/RGC 
markers such as Musashi1 and BLBP, Notch signalling-related genes such as 
Notch1 and Hes5, FGF signalling-related genes such as FGFR2 and Hedgehog 
signalling-related genes. The young basal progenitors had a distinct high 
expression level of the Delta signal Dll1. NSC/RGC markers and Notch, FGF 
and Hedgehog signalling-related factors are crucial in maintaining the apical 
and young basal progenitors in their early undifferentiated state and Delta 
signals ensure neighboring progenitors are at their early developmental stage. I 
observed that similar to the apical and young basal progenitors, cluster US1 
had high expression of Musashi1, BLBP, Notch1, Hes5, FGFR2, Hedgehog 
signalling related genes such as Gli1 and Gli2 and Delta signals Dll1 and Dll3 
(Figures 3.3 and 3.4). This indicates that cluster US1 consists of cells 
resembling apical and young basal progenitors and is likely to be at an early 
developmental stage. Cluster US1 also showed high expression of NSC-
related genes such as Bmi1, POU3F2 and Prominin1. Knockout and 
knockdown studies have demonstrated that Bmi1 is important for NSC self-
renewal and maintenance of the NSC pool in vitro and in vivo [240-244]. 
POU3F2 is involved in repression of NSC differentiation [245, 246] and 
Prominin1 enriches for NSCs [130]. Since the earliest cells that occur during 
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development are NSCs, it further supports that cells in cluster US1 are at an 
early developmental stage. 
Genes such as Bmi1, Hes5, POU3F2, Gli1, Gli2 and BLBP which were 
expressed at a higher level in cluster US1 were expressed at a lower level in 
cluster US3 and genes such as Myc and Klf12 which were expressed at a lower 
level in cluster US1 were expressed at a higher level in cluster US3 (Figures 
3.3 and 3.4). Thus it appears that cluster US3 has a near opposite mRNA 
profile to that of cluster US1. In addition, cluster US3 had low expression of 
Pax6 whose expression has been shown to decline over development when 
RGCs give rise to intermediate progenitor cells [65]. Taken together, cells in 
cluster US3 are at a late developmental stage.                                                                 
Cluster US2 seems to show features of cluster US1 in its high 
expression of Bmi1 and Hes5 and low expression of Klf12, and features of 
cluster US3 in its high expression of Myc (Figures 3.3 and 3.4). Furthermore, 
cluster US2 showed significant changes in only 9 genes compared to cluster 
US1 and US3 combined. This suggests that the other genes are probably 
expressed at an intermediate level compared to clusters US1 and US3. Thus, 
cells in cluster US2 are likely to be cells at an intermediate developmental 
stage transiting between clusters US1 and US3.  
To verify whether the differences in mRNA levels are due to actual 
differences between clusters or due to stochastic noise, violin plots were 
derived from the expression data (Figure 3.5). Actual gene expression 
differences between clusters exhibit a multimodal distribution while stochastic 
noise exhibits a unimodal distribution. The plot for Beta-actin is unimodal 
indicating minimal variation between the cells whereas the plots for genes 
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such as Bmi1 and Hes5 are multimodal indicating clusters with distinct 




Figure 3.5 Violin plots for expression in unsorted cells.  
Violin plots for the expression of each of the 48 genes in passage 2 unsorted 
cells. Actual gene expression differences exhibit a multimodal distribution 
while stochastic noise exhibits a unimodal distribution. This work was done in 
collaboration with Anuradha Poonepalli (Institute of Medical Biology, 
Singapore) and Chen Jinmiao (Singapore Immunology Network, Singapore). 
Reproduced with permission from my published paper Narayanan et al., 2012, 











3.2 Deriving a suitable population to identify a neurosphere-forming 
cell cluster 
I sought to identify which of the three progenitor subclasses, early, 
intermediate or late, forms neurospheres (i.e. NFC cluster). The percentage of 
NFCs in the unsorted population is 4.88 ± 0.50% and 14.6 ± 5.25% at low 
density and clonal density respectively (Figures 3.8A and 3.8B). Cell 
aggregation could be a contributory factor to why a lower percentage of NFCs 
is observed at low density. NFCs are not well-represented in the unsorted 
population at both densities and hence using this population to detect an NFC 
cluster would be challenging. Instead, a population with higher neurosphere-
forming potential would help detect an NFC cluster.  
Previous studies have shown enrichment of NSCs based on cell size 
and granularity [113, 154]. Thus I used morphological criteria of FSC (cell 
size) and SSC (granularity) to obtain a population with higher neurosphere-
forming potential. Gates were set up to sort passage 2 cells as FSC/SSC high or 
FSC/SSC low cells (Figure 3.6A). Doublet discrimination using SSC-W/SSC-H 
and FSC-W/FSC-H gatings ensured that only singlets were used for all 
experiments (Figure 3.6B - E). I observed that majority (75.2 ± 9.78%) of 
neurosphere cells were FSC/SSC low cells while a small percentage (4.62 ± 
2.37%) was FSC/SSC high cells (Figure 3.7). 
3.2.1 Enrichment of neurosphere-forming cells in the FSC/SSC high 
population   
The neurosphere-forming capacity of the FSC/SSC high, FSC/SSC low 
and unsorted populations was assessed. From the NFA, the percentage of 
NFCs was higher in the FSC/SSC high population (11.91 ± 2.03%) than in the 
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FSC/SSC low population (4.07 ± 1.15%) and the unsorted population (4.87 ± 
0.50%) at low density (Figure 3.8A). At low density, cell aggregation may 
occur which would complicate enumeration of neurospheres. To avoid 
aggregation, the NFA was also done at clonal density (1 cell/well). Similar to 
at low density, the percentage of NFCs was higher in the FSC/SSC high 
population (31.3 ± 7.79%) than in the FSC/SSC low population (15.2 ± 4.71%) 
and the unsorted population (14.6 ± 5.25%) at clonal density (Figure 3.8B). 
The FSC/SSC high population had a 2.29-fold and a 2.54-fold higher 
neurosphere formation than the FSC/SSC low and unsorted population 
respectively at clonal density (Figure 3.8C). Hence, the FSC/SSC high is 
enriched for NFCs compared to the FSC/SSC low and unsorted populations. 
 
Figure 3.6 Sorting of neurosphere cells based on morphological 
characteristics.  
(A)FSC/SSC high and FSC/SSC low populations from passage 2 E14.5 
neurosphere cells were gated based on FSC/SSC signal intensity. (B, C) 
FSC/SSC low singlets and (D, E) FSC/SSC high singlets were gated by 
performing doublet discrimination using SSC-W/SSC-H and FSC-W/FSC-H 

























Figure 3.7 Percentage of FSC/SSC high and FSC/SSC low cells in unsorted 
population. 
Percentage of FSC/SSC high and FSC/SSC low cells was calculated in total live 
cell population (mean ± SD; n = 5; ***P≤0.001). Abbreviations: FSC, forward 
scatter; SSC, side scatter. This work was done in collaboration with Anuradha 
Poonepalli (Institute of Medical Biology, Singapore). Reproduced and 
modified with permission from my published paper Narayanan et al., 2012, 


























Figure 3.8 Neurosphere-forming potential of FSC/SSC high, FSC/SSC low and unsorted 
population. 
Neurosphere formation expressed as NFU which is the number of neurospheres formed for 
every 100 cells plated. NFA was performed at (A) low density (1000 cells/ml) (mean ± SD; n 
= 5; ***P≤0.001) and (B) at clonal density (1 cell/well) (mean ± SD; n = 4; *P≤0.05). (C) 
Fold difference in NFU for FSC/SSC high compared with FSC/SSC low cells or unsorted cells 
at low and clonal density (mean ± SD; n ≥ 4). Abbreviations: FSC, forward scatter; SSC, side 
scatter; NFU, neurosphere-forming units; NFA, neurosphere formation assay. This work was 
done in collaboration with Anuradha Poonepalli (Institute of Medical Biology, Singapore). 
Reproduced and modified with permission from my published paper Narayanan et al., 2012, 
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3.2.2 Characterization of FSC/SSC-sorted populations 
I investigated specific characteristics of the FSC/SSC sorted 
populations and observed the following: (i) FSC/SSC high cells are on average 
bigger in size than FSC/SSC low cells (Figure 3.9A). Bigger cells also tend to 
lead to higher NFU than smaller cells (Figure 3.9B) (ii) Surface expression of 
two molecules closely linked with NSCs was analyzed – phosphacan and LeX 
[112, 120, 126, 247, 248]. The average surface expression of phosphacan 
(Figure 3.10) and LeX (Figure 3.11) was higher in the FSC/SSC high population 
than in the FSC/SSC low population. Almost all FSC/SSC high cells (97.83 ± 
3.53%) were LeX+ve (Figure 3.11A). (iii) NSC characteristics; (a) The 
FSC/SSC high population led to a lower percentage of small neurospheres 
(<50µM) and appears to lead to a higher percentage of large spheres (>50µM) 
than the FSC/SSC low population (Figure 3.12A) indicating higher proliferation 
ability. (b) The FSC/SSC high population had a significantly higher secondary 
neurosphere formation and hence a greater self-renewal potential than the 
FSC/SSC low and unsorted population (Figure 3.12B) (c) A higher percentage 
of tripotent neurospheres was observed in the FSC/SSC high population 
compared to the FSC/SSC low population (Figure 3.13A and Figure 3.13B) (d) 
The NSC frequency, which is the product of the NFU at clonal density and 
percentage of tripotent neurospheres [120, 121], was higher in the FSC/SSC 
high population (5.36 ± 1.46%) than in the FSC/SSC low population (1.26 ± 
1.34%) and the unsorted population (0.82 ± 0.87%) (Figure 3.13C) Taken 
together, the FSC/SSC high population is significantly enriched for NSCs 









Figure 3.9 Cell size of FSC/SSC high and FSC/SSC low population and correlation with 
neurosphere formation. 
(A) Average size of FSC/SSC high and FSC/SSC low cells (mean ± SD; n = 22 and n = 15 for 
FSC/SSC high and FSC/SSC low cells respectively; *P≤0.05). (B) Correlation of neurosphere 
formation to cell size range (mean ± SD; n = 4; *P≤0.05). Passage 2 cells were used for 
experiments. Abbreviations: FSC, forward scatter; SSC, side scatter; NFU, neurosphere-
forming units. This work was done in collaboration with Anuradha Poonepalli (Institute of 
Medical Biology, Singapore). Reproduced and modified with permission from my published 
paper Narayanan et al., 2012, Figures 4A and 4B [236]. 
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Figure 3.10 Surface expression of phosphacan in FSC/SSC high and FSC/SSC low population. 
(A) 57 FSC/SSC high and 1564 FSC/SSC low cells were stained for phosphacan and the fluorescence intensity was measured (mean 
± SD; ***P≤0.001). (B) Phosphacan intensity distribution in FSC/SSC high and FSC/SSC low cells. Passage 2 cells were used for 
experiments. Abbreviations: FSC, forward scatter; SSC, side scatter. This work was done in collaboration with Anuradha 
Poonepalli (Institute of Medical Biology, Singapore). Reproduced and modified with permission from my published paper 
Narayanan et al., 2012, Figures 4C and 4D [236]. 
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Figure 3.11 Surface expression of LeX in FSC/SSC high and FSC/SSC low population. 
(A) Percentage of LeX positive and negative cells in the FSC/SSC high and FSC/SSC low 
populations (mean ± SD; n = 4; **P≤0.01). (B) Intensity distribution of LeX in the FSC/SSC 
high and FSC/SSC low populations. FITC-conjugated anti-LeX antibody was used to stain cells 
and the fluorescence intensity of 1000 cells per population was measured. Passage 2 cells 
were used for experiments. Abbreviations: FSC, forward scatter; SSC, side scatter; LeX, 
Lewis-X; FITC, Fluorescein isothiocyanate. Reproduced and modified with permission from 
my published paper Narayanan et al., 2012, Figures 4E and 4F [236]. 
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Figure 3.12 Proliferation and self-renewal capacity of FSC/SSC high and FSC/SSC low cells.  
(A) Size of neurospheres derived from FSC/SSC high and FSC/SSC low cells. Neurospheres 
smaller than 50 µm, 50 to 100 µm and larger than 100 µm in diameter were counted (mean ± 
SD; n = 4; **P≤0.01). (B) Secondary NFA performed for the FSC/SSC high, FSC/SSC low and 
unsorted population at low density (1000 cells/ml) (mean ± SD; n = 4; **P≤0.01, 
***P≤0.001). Passage 2 cells were used for experiments. Abbreviations: FSC, forward 
scatter; SSC, side scatter; NFA, neurosphere formation assay; NFU, neurosphere- forming 
units. This work was done in collaboration with Anuradha Poonepalli (Institute of Medical 
Biology, Singapore). Reproduced and modified with permission from my published paper 
Narayanan et al., 2012, Figures 5A and 5B [236]. 
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Figure 3.13 Multipotency and NSC frequency in FSC/SSC high and FSC/SSC 
low population. 
(A) Enumeration of unipotent, bipotent and tripotent neurospheres after single 
neurosphere differentiation (mean ± SD; n = 4; *P≤0.05). (B) Immunostaining 
of a single tripotent neurosphere; O4 (green), βIII-tubulin (red), GFAP (grey). 
Scale bar = 50 µm. Image was taken with a 20x objective. (C) NSC frequency 
calculated as product of NFU at clonal density and percentage of tripotent 
neurospheres (mean ± SD; n = 4; **P≤0.01). Passage 2 cells were used for 
experiments. Abbreviations: NSC, neural stem cell; FSC, forward scatter; 
SSC, side scatter; GFAP, glial fibrillary acidic protein. This work was done in 
collaboration with Anuradha Poonepalli (Institute of Medical Biology, 
Singapore). Reproduced and modified with permission from my published 














































3.3 Single-cell mRNA profiling of FSC/SSC-sorted cells  
I performed single-cell mRNA profiling on 170 passage 2 FSC/SSC 
high cells and 181 passage 2 FSC/SSC low cells. The same 48 genes profiled in 
unsorted cells were used (Table 3.1). The expression data for both FSC/SSC 
high and FSC/SSC low cells was combined and clustering was performed by 
nMDS and Mclust. Three clusters were derived – S (Size/granularity) 1, S2 
and S3 (Figure 3.14). The prefix “S” is used to label the clusters to denote that 
the cells were sorted according to size/granularity prior to single-cell mRNA 
profiling. The heatmap and expression bar plots obtained from the expression 
data showed that 35 genes were significantly expressed at a higher or lower 
level in cluster S1 compared to clusters S2 and S3 combined (Figures 3.15 and 
3.16). Violin plots demonstrate that the differences in mRNA levels between 
clusters do not result from stochastic noise (Figure 3.17).  
Cluster S1 showed high expression of mitogen-related genes such as 
FGFR2, FGFR1, EGFR, Notch signalling-related genes such as Hes5, Hes1, 
Jag1, Hedgehog signalling-related genes such as Gli1 and Gli2 and low 
expression of Myc, Olig1 and Olig2. Interestingly, cluster S1 had low 
expression of some NSC-related genes such as Musashi1 and Nestin and high 
expression of other NSC-related genes such as GLAST and BLBP. Cluster S2 
had high expression of specific early developmental genes such as Dll1 and 
Dll3 and had low expression of other early developmental genes such as Hes5 
and FGFR2. Cluster S3 had low expression of specific early developmental 




Figure 3.14 Single-cell mRNA profiling of FSC/SSC high and FSC/SSC low 
cells.  
nMDS was used to compress 48-dimensional mRNA profiling data of 170 
FSC/SSC high and 181 FSC/SSC low cells to two dimensions. Axes are labeled 
as nMDS_1 and nMDS_2 for the two dimensions. Mclust obtained three 
clusters from FSC/SSC high (filled circles) and FSC/SSC low (open circles) cells 
– clusters S1 (red), S2 (green) and S3 (blue). Passage 2 cells were used. 
Abbreviations: FSC, forward scatter; SSC, side scatter; nMDS, non-metric 
multi-dimensional scaling. This work was done in collaboration with 
Anuradha Poonepalli (Institute of Medical Biology, Singapore) and Chen 
Jinmiao (Singapore Immunology Network, Singapore). Reproduced with 






Figure 3.15 Heatmap showing the mRNA profile of clusters S1, S2 and S3. 
Each row and column represents one cell and one gene respectively. Genes 
under the P<0.05 section are genes showing a statistically significant change 
in expression in cluster S1 compared to clusters S2 and S3 combined. Red and 
green colours represent high and low expression respectively. This work was 
done in collaboration with Anuradha Poonepalli (Institute of Medical Biology, 
Singapore) and Chen Jinmiao (Singapore Immunology Network, Singapore). 
Reproduced with permission from my published paper Narayanan et al., 2012, 





































Figure 3.16 Genes with significant change in expression in clusters S1, S2 and S3. 
Log2 fold change in gene expression for genes which show significant change in expression (P<0.05) in a cluster in comparison 
with the remaining clusters combined. Panels (A), (B) and (C) show bar graphs for cluster S1, S2 and S3 respectively. This work 
was done in collaboration with Anuradha Poonepalli (Institute of Medical Biology, Singapore) and Chen Jinmiao (Singapore 





 Figure 3.17 Violin plots for expression in FSC/SSC high and FSC/SSC low cells.  
Violin plots for the expression of each of the 48 genes in 170 FSC/SSC high and 
181 FSC/SSC low cells. Actual gene expression differences exhibit a 
multimodal distribution while stochastic noise exhibits a unimodal 
distribution. Passage 2 cells were used. Abbreviations: FSC, forward scatter; 
SSC, side scatter. This work was done in collaboration with Anuradha 
Poonepalli (Institute of Medical Biology, Singapore) and Chen Jinmiao 
(Singapore Immunology Network, Singapore). Reproduced with permission 









3.4 Cluster S1 represents a neurosphere-forming cell cluster  
The FSC/SSC high population had a 2.29-fold higher NFC percentage 
than the FSC/SSC low population at clonal density (Figure 3.8C). If all the 
NFCs from the FSC/SSC high and FSC/SSC low population were to form one 
cluster (i.e. NFC cluster), the ratio of FSC/SSC high to FSC/SSC low cells in that 
cluster would be about 2.29. Hence, I checked the ratio of FSC/SSC high to 
FSC/SSC low cells in the three clusters and found that cluster S1 had a ratio of 
2.1 while clusters S2 and S3 which had a ratio of 0.53 and 1.15 respectively 
(Table 3.2). This suggests that the NFC cluster is likely to be cluster S1. In 
addition 25.9% of all FSC/SSC high cells and 12.1% of all FSC/SSC low cells 
analyzed belonged to cluster S1 (Table 3.2). These percentages are 
comparable with the percentage of NFCs in the FSC/SSC high cells (31.3%) 
and FSC/SSC low cells (15.2%) obtained from the NFA at clonal density 
(Figure 3.8B). However, the percentages obtained from clusters S2 and S3 are 
not comparable with the data from the NFA.  
I also analyzed the probability that cluster S1 is formed by chance. 
Random clustering of FSC/SSC high and FSC/SSC low cells was performed 
1000 times to form a cluster of 66 cells (number of cells in cluster S1). The 
ratio of FSC/SSC high to FSC/SSC low cells in the cluster formed was calculated 
each time.  A distribution curve showing the probability of obtaining a cluster 
with specific FSC/SSC high to FSC/SSC low ratios was constructed (Figure 
3.18). From the distribution curve, the probability of obtaining a cluster with 
FSC/SSC high to FSC/SSC low ratio of 2.1 by chance is not statistically 
significant. My data strongly suggest that cluster S1 is the NFC cluster. 
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* Expected values for NFC cluster are based on NFA at clonal density (see Figure 3.8B) 
Table is reproduced with permission from my published paper Narayanan et al., 2012, Figure 7A [236].
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 Figure 3.18 Distribution curve reflecting the probability of obtaining clusters with specific 
FSC/SSC high to FSC/SSC low cell ratio.  
Single-cell mRNA data from passage 2 FSC/SSC high and FSC/SSC low cells were combined 
and 66 cells (number of cells in cluster S1) were picked randomly to form a cluster and the 
ratio of FSC/SSC high to FSC/SSC low cells was determined. This procedure was repeated 
1000 times to derive the distribution curve. The x-axis values 0.5 and 1.5 are the boundaries 
at 99% significance level. Note that the ratio 2.1 does not fall within this region showing that 
cluster S1 is not formed by chance. Abbreviations: FSC, forward scatter; SSC, side scatter. 
This work was done in collaboration with Anuradha Poonepalli (Institute of Medical Biology, 
Singapore) and Chen Jinmiao (Singapore Immunology Network, Singapore). Reproduced 
with permission from my published paper Narayanan et al., 2012, Figure 7B [236]. 
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3.5 Cluster S1 cells belong to the early progenitor subclass 
To determine the developmental profile of cluster S1 cells, I mapped 
cluster S1 cells onto the early, intermediate and late cells from the unsorted 
population (Figure 3.19). Most, if not all of cluster S1 cells mapped closely to 
the early cell cluster (cluster US1), demonstrating that cluster S1 comprises of 
early progenitors. Cluster S2 cells mapped onto the early and the intermediate 
clusters while cluster S3 cells mapped onto the early, intermediate and late 
clusters.  
Since cluster S1 consists of early progenitors, I reasoned that NFCs 
belong to the early progenitor subclass. This was validated through NFA and 
single-cell mRNA profiling of passage 2 and 5 neurosphere cells. Passage 2 
cells are presumed to be enriched with early progenitors compared to passage 
5 cells which develop across their longer time in culture. Passage 2 cells have 
increased neurosphere formation than passage 5 cells which could be due to 
the enrichment of early progenitors in passage 2 cells (Figure 3.20A).   
 Single-cell mRNA profiling showed that eight genes (Jag1, Hes1, 
GLAST, REST, Nestin, Tead2, FGFR1 and Bystin-like) were expressed at a 
higher level by at least 1.3-fold in passage 2 cells compared to passage 5 cells 
(Figure 3.20B). Of these eight genes, six (Jag1, Hes1, GLAST, REST, Tead2 
and FGFR1) were also expressed at a higher level in cluster S1 (Figure 3.16A) 
highlighting similar gene expression patterns between passage 2 cells 


























Figure 3.19 nMDS mapping of clusters S1, S2 and S3 onto early, intermediate and late 
clusters.  
nMDS mapping of (A) clusters S1 (red), (B) S2 (green) and (C) S3 (blue) onto clusters US1 
(yellow), US2 (black) and US3 (orange). The proposed type of cells in clusters S1, S2 and S3 
[as interpreted from Figure 4.19] is shown in Table 4.2. Abbreviations: FSC, forward scatter; 
SSC, side scatter; nMDS, non-metric multi-dimensional scaling.  This work was done in 
collaboration with Anuradha Poonepalli (Institute of Medical Biology, Singapore) and Chen 
Jinmiao (Singapore Immunology Network, Singapore). Reproduced and modified with 

































Figure 3.20 NFA and single-cell mRNA profiling of passage 2 and 5 cells.  
(A) Neurosphere formation expressed as NFU which is the number of neurospheres formed 
per 100 cells plated. NFA was performed at clonal density (1 cell/well) after FACS sorting 
passage 2 and passage 5 cells (mean ± SD; n = 4; ***P≤0.001). (B) Single-cell mRNA 
profiling was performed on 190 passage 2 and 191 passage 5 neurosphere cells. Bar plots 
show the fold change in expression level of the 8 genes which were expressed at a higher 
level by at least 1.3-fold in passage 2 compared to passage 5 cells. The fold change in 
expression in passage 2 cells was calculated relative to passage 5 cells (given a value of 1). 
Abbreviations: NFU, neurosphere-forming units; NFA, neurosphere formation assay. 
Reproduced and modified with permission from my published paper Narayanan et al., 2012, 
























































4 RESULTS: IDENTIFICATION OF NEURAL STEM CELLS AND 
NEURAL PROGENITORS 
4.1 Deriving a suitable population to identify a neural stem cell cluster 
Next, I sought to identify an NSC cluster. The FSC/SSC high population 
had an NSC frequency of 5.36 ± 1.46% (Figure 3.13C). Using this population 
to identify an NSC cluster through single-cell mRNA profiling would be 
challenging. LeX and Prominin1 are the most established NSC markers [112, 
126, 129, 130]. Prominin1 has been shown to enrich for NSCs in primary cells 
isolated from human fetal [129] and mouse developing and adult brain [130]. 
However, the effectiveness of Prominin1 as an NSC marker in neurospheres 
has not been determined. Recent work demonstrated that LeX and Prominin1 
expression could be independently used to increase the NFU although 
Prominin1 expression leads to a lower NSC enrichment compared to LeX 
expression (Mike Yu and Sohail Ahmed, unpublished). In addition, Prominin1 
expression when used with LeX expression does not result in further 
enrichment of NFU (Mike Yu and Sohail Ahmed, unpublished). Hence, I did 
not use Prominin1 expression to further enrich for NSCs.  
Recent work identified a population which had high surface expression 
of LeX and CD93 (Mike Yu and Sohail Ahmed, unpublished). The NSC 
frequency of the LeX+ve CD93+ve and LeX+ve CD93-ve population is 45.86 ± 
3.08% and 10.32 ± 0.55% respectively, showing that CD93 expression when 
used with LeX expression results in significant enrichment of NSCs (Mike Yu 
and Sohail Ahmed, unpublished). Both populations are enriched for NSCs 
compared to the FSC/SSC high population. Hence I selected the LeX+ve 
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CD93+ve and LeX+ve CD93-ve populations for single-cell mRNA profiling to 
identify an NSC cluster (Figure 4.1).   
 
4.2 Characterization of LeX+ve CD93+ve population 
4.2.1 Surface expression of Notch1, Dll1, EGFR and CXCR4 in LeX+ve 
CD93+ve population  
I characterized the LeX+ve CD93+ve population by analyzing the surface 
expression of four proteins, Notch1, Dll1, EGFR and CXCR4. Notch1 and 
Dll1 represent a surface receptor and ligand of the Notch signalling pathway 
respectively which is one of the important pathways that is crucial for NSC 
self-renewal, maintenance and cell fate [141, 175, 249, 250]. In particular, 
Notch1 has been implicated in maintenance of adult hippocampal NSCs [251] 
and used in the enrichment of embryonic NSCs [132]. The EGFR and CXCR4 
signalling pathways act as major pathways which promote the survival and 
proliferation of NSCs/NPs [92, 93, 120, 137, 252]. Here I analyzed the surface 
expression of Notch1, Dll1, EGFR and CXCR4 using specific fluorescence-
labeled antibodies and FACS histogram analysis. Strikingly, LeX+ve CD93+ve 
cells show a significantly higher surface expression of Notch1 (Figure 4.2B, E, 
F), Dll1 (Figure 4.3B, E, F), EGFR (Figure 4.4B, E, F) and CXCR4 (Figure 
4.5) compared to unsorted cells. Furthermore, LeX+ve CD93+ve cells show a 
higher expression of Notch1 (Figure 4.2C, D, E, F), Dll1 (Figure 4.3C, D, E, 
F) and EGFR (Figure 4.4C, D, E, F) compared to LeX+ve cells or CD93+ve 
cells. LeX+ve or CD93+ve cells also show higher expression of Notch1 (Figure 
4.2B, C, D), Dll1 (Figure 4.3B, C, D) and EGFR (Figures 4.4B, C, D) 
compared to unsorted cells. Taken together, the LeX+ve CD93+ve population is 
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enriched for cells with NSC characteristics compared to the LeX+ve, CD93+ve 

















Figure 4.1 Sorting LeX+ve CD93+ve cells by FACS. 
Dissociated neurosphere-derived cells are stained with FITC-conjugated anti- mouse LeX and 
PE-conjugated anti- mouse CD93 antibodies and sorted by FACS. (A) and (B) show FACS 
profiles of unstained cells (background control) and stained cells respectively. x-axis and y-
axis show FITC and PE signals respectively. Gates were set up to isolate LeX+ve CD93+ve 
cells (DP cells). Abbreviations: LeX, Lewis-X; FACS. Fluorescence activated cell sorting; 



































Figure 4.2 Surface expression of Notch1 in LeX+ve CD93+ve population. 
Cells were stained with APC-conjugated anti- mouse Notch1 antibody and analyzed by 
FACS. FACS histograms showing the number of cells having specific Notch1 expression in 
(A) background control (unstained), (B) unsorted, (C) LeX+ve, (D) CD93+ve and (E) LeX+ve 
CD93+ve population. The gate in each histogram defines Notch1 positive signal. (F) 
Percentage of Notch1+ve cells in the different populations as determined from the histograms 
(mean ± SD; n = 4; ***P≤0.001). Abbreviations: LeX, Lewis-X; APC, allophycocyanin; 





    


































































Figure 4.3 Surface expression of Dll1 in LeX+ve CD93+ve population. 
Cells were stained with APC-conjugated anti- mouse Dll1 antibody and analyzed by FACS. 
FACS histograms showing the number of cells having specific Dll1 expression in (A) 
background control (unstained), (B) unsorted, (C) LeX+ve, (D) CD93+ve and (E) LeX+ve 
CD93+ve population. The gate in each histogram defines Dll1 positive signal. (F) Percentage 
of Dll1+ve cells in the different populations as determined from the histograms (mean ± SD; n 
= 4; ***P≤0.001). Abbreviations: LeX, Lewis-X; APC, allophycocyanin; FACS, 









    
A B C 
D E 
F 
      




























































Figure 4.4 Surface expression of EGFR in LeX+ve CD93+ve population. 
Cells were stained with APC-conjugated anti- mouse EGFR antibody and analyzed by FACS. 
FACS histograms showing the number of cells having specific EGFR expression in (A) 
background control (unstained), (B) unsorted, (C) LeX+ve, (D) CD93+ve and (E) LeX+ve 
CD93+ve population. The gate in each histogram defines EGFR positive signal. (F) 
Percentage of EGFR+ve cells in the different populations as determined from the histograms 
(mean ± SD; n = 4; *P≤0.05; **P≤0.01; ***P≤0.001). Abbreviations: EGFR, epidermal 
growth factor receptor; LeX, Lewis-X; APC, allophycocyanin; FACS, fluorescence activated 
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Figure 4.5 Surface expression of CXCR4 in LeX+ve CD93+ve population. 
Cells were stained with PE/Cy7-conjugated anti- mouse CXCR4 antibody and analyzed by 
FACS. Percentage of CXCR4+ve cells in unsorted and LeX+ve CD93+ve population was 
determined (mean ± SD; n = 4; ***P≤0.001). Abbreviations: LeX, Lewis-X; PE, 
phycoerythrin; FACS, fluorescence activated cell sorting. 
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4.2.2 Expression of Hes1 in LeX+ve CD93+ve population 
Hes1 is a transcription factor which has been shown to promote NSC 
self-renewal and proliferation while repressing NSC differentiation [183-187]. 
I used primary cells directly isolated from E14.5 Hes1-GFP mouse brain to 
analyze Hes1 expression in five specific cell populations – unsorted, LeX-ve 
CD93-ve, LeX-ve CD93+ve, LeX+ve CD93-ve and LeX+ve CD93+ve cells. The LeX-
ve CD93+ve population showed higher Hes1 expression compared to LeX-ve 
CD93-ve population indicating that CD93 by itself enriches for Hes1-
expressing cells (Figure 4.6). Similarly, LeX by itself enriches for Hes1-
expressing cells as LeX+ve CD93-ve population showed higher Hes1 expression 
compared to LeX-ve CD93-ve population, although the enrichment was not as 
marked as that by CD93 (Figure 4.6). When used in combination, the LeX+ve 
CD93+ve population had significant enrichment of Hes1-expressing cells 
compared to unsorted and LeX-ve CD93-ve population (Figure 4.6). These 




























































Figure 4.6 Expression of Hes1 in LeX+ve CD93+ve population. 
Primary cells derived from brain cortex of E14.5 Hes1-GFP mice were stained with 
antibodies specific to LeX and CD93. The percentage of Hes1-GFP+ve cells in different 
populations was analyzed by FACS (mean ± SD; n = 4; ***P≤0.001). Abbreviations: LeX, 




4.3 Single-cell mRNA profiling of LeX+ve CD93+ve and LeX+ve CD93-ve 
cells 
To identify NSCs, I profiled the mRNA levels of 48 genes (Table 3.1) 
in single cells of the LeX+ve CD93+ve and LeX+ve CD93-ve populations. I 
profiled 172 cells each from LeX+ve CD93+ve and LeX+ve CD93-ve population, 
combined the expression data and clustered the cells using nMDS and Mclust. 
Three clusters were obtained– cluster L (LeX/CD93)1, L2 and L3 (Figure 
4.7). The prefix “L” is used to label the clusters to denote that the cells were 
sorted according to LeX/CD93 expression prior to single-cell mRNA 
profiling.  
4.4 Clusters L1, L2 and L3 represent neural stem cells, bi/unipotent 
neural progenitors and non-neurosphere-forming cells respectively 
Three types of cells could exist within the LeX+ve CD93+ve and LeX+ve 
CD93-ve populations – non-NFCs (cells that do not form neurospheres), 
bi/unipotent NPs (cells that form bi/unipotent neurospheres) and NSCs (cells 
that form tripotent neurospheres). LeX+ve CD93+ve population has a 4.44-fold 
higher NSC frequency than the LeX+ve CD93-ve population (Mike Yu and 
Sohail Ahmed, unpublished). If all the NSCs from the LeX+ve CD93+ve and 
LeX+ve CD93-ve population were to form one cluster (i.e. NSC cluster), the 
ratio of LeX+ve CD93+ve to LeX+ve CD93-ve cells in this cluster would be 4.44 
(Table 4.1). By similar analysis, the ratio of LeX+ve CD93+ve to LeX+ve CD93-ve 
cells in a bi/unipotent cluster and in a non-NFC cluster would be 0.57 and 0.61 
respectively (Table 4.1). I therefore checked the ratio of LeX+ve CD93+ve to 
LeX+ve CD93-ve cells in the three clusters and found that cluster L1 had a ratio 
127 
 
of 4.26 while clusters L2 and L3 had a ratio of 0.64 and 0.57 respectively, 
suggesting that cluster L1 could be the NSC cluster (Table 4.2). It is difficult 
to determine which cluster represents bi/unipotent cells or non-NFCs as the 
ratios for clusters L2 and L3 are similar.  
The NSC frequency of the LeX+ve CD93+ve and LeX+ve CD93-ve 
population is 45.86 ± 3.08% and 10.32 ± 0.55% respectively (Mike Yu and 
Sohail Ahmed, unpublished). Calculations using the NSC frequency in the 
LeX+ve CD93+ve and LeX+ve CD93-ve population show that the percentage of 
total cells analyzed that would fall in the NSC cluster would be 28.09% (Table 
4.1). By similar analysis, the percentage of total cells analyzed that would fall 
in the bi/unipotent cluster and non-NFC cluster would be 14.42% and 57.5% 
respectively (Table 4.1). The percentage of total cells analyzed that fell in 
cluster L1, L2 and L3 was 29.1%, 21.5% and 49.4% respectively (Table 4.2). 
By comparison with the expected percentages for an NSC, bi/unipotent NP 
and non-NFC cluster, I deduced that cluster L1, L2 and L3 are likely to be the 
NSC cluster, bi/unipotent NP cluster and non-NFC cluster respectively. 
A heatmap (Figure 4.8) and expression bar plots (Figure 4.9) showing 
the genes that were significantly expressed at a higher or lower level in one 
cluster compared to the other two clusters combined were derived. Cluster L1 
cells had high expression of genes involved in two major signalling pathways 
in NSCs – Notch and Shh (Figure 4.9A) [141, 142, 175, 215, 249, 250, 253-
255]. Notch signalling-related genes such as Notch1, Jag1, Hes1 and Hes5 and 
Shh signalling-related gene, Gli2 were expressed at a high level in cluster L1. 
These cells also seem to be highly proliferative due to the high expression of 
growth factor receptors FGFR1 and FGFR2. In addition, high expression of 
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known NSC or RGC markers such as GLAST and BLBP further support the 
NSC characteristics of cluster L1. Dll1, a Notch ligand, had the lowest 
expression in cluster L1. Perhaps cluster L1 cells have a low surface 
expression of Dll1 which in turn minimizes activation of Notch receptors on 
surrounding NPs in a process known as lateral inhibition [143]. Klf12, which 
is expressed at a low level in early developmental cells (Figure 3.4A), and 
Olig1 [145, 146, 256] and Sox9 [144] which are involved in oligodendrocyte 
differentiation, are expressed at a low level in cluster L1. This indicates that 
cluster L1 cells are probably at an early undifferentiated state, a feature of 
NSCs. 
Cluster L2 showed similar patterns with cluster L1 in its high 
expression level of Hes5, GLAST, FGFR2, Hes1, BLBP, FGFR1 and low 
expression level of Dll1 and Klf12 (Figure 4.9B). However, unlike cluster L1, 
cluster L2 did not have high expression level of Notch1, Jag1 and Gli2, genes 
which are crucial for self-renewal, proliferation and maintenance of NSCs in 
their undifferentiated state [187, 212, 215, 251, 257]. Cluster L2 also had high 
expression level of Myt1l and Sox9 which are involved in neuronal and 
oligodendroglial differentiation respectively [144, 148, 149], and no longer 
shows a low expression level of Olig1.  This indicates that cluster L2 cells are 
more committed towards differentiation into specific lineages than cluster L1 
cells, suggesting that cluster L2 represents bi/unipotent NPs. 
Cluster L3 had low expression level of NSC-related genes such as 
Hes1/5 [183-187], FGFR2 [258, 259], Gli2 [212, 215], Jag1 [187, 257], 
GLAST [171], Pax6 [65, 157], BLBP [165, 167], FGFR1 [99, 258-260], 
Notch1 [132, 251], Nestin [40, 172] and β-catenin [195] (Figure 4.9C), 
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indicating that these cells have limited self-renewal and proliferative capacity. 
Cluster L3 had high expression level of Klf12, which is highly expressed in 
late developmental cells (Figure 3.4C). It also had high expression level of the 
differentiation genes Olig1 [145, 146, 256] and Mash1 [150-152, 261], 
suggesting that cluster L3 cells are late developmental cells which are 
differentiating and do not have the proliferative capacity to form neurospheres 
(non-NFCs). Cluster L3 cells had a high expression level of Dll1 which 
perhaps binds to Notch1 receptors on neighbouring cells such as cluster L1 
cells. This maintains the neighbouring cells as NSCs.   
I analyzed the probability that cluster L1 is formed by chance. Random 
clustering of LeX+ve CD93+ve and LeX+ve CD93-ve cells was performed 1000 
times to form a cluster of 100 cells (number of cells in cluster L1). The ratio of 
LeX+ve CD93+ve to LeX+ve CD93-ve cells in the cluster formed was calculated 
each time.  A distribution curve showing the probability of obtaining a cluster 
with specific LeX+ve CD93+ve to LeX+ve CD93-ve ratios was constructed (Figure 
4.10A). From the distribution curve, the probability of obtaining a cluster with 
LeX+ve CD93+ve to LeX+ve CD93-ve ratio of 4.26 by chance is not statistically 
significant. Similar analysis for clusters L2 and L3 also showed that the 
probability of obtaining these clusters by chance is not statistically significant 























Figure 4.7 Single-cell mRNA profiling of LeX+ve CD93+ve and LeX+ve CD93-ve 
cells.  
48-dimensional mRNA profiling data of 172 cells each from LeX+ve CD93+ve 
and LeX+ve CD93-ve population was compressed to two dimensions by nMDS. 
Axes for the two dimensions are labeled as nMDS_1 and nMDS_2. Mclust 
derived three clusters from LeX+ve CD93+ve (filled circle) and LeX+ve CD93-ve 
(open circle) cells – cluster L1 (blue), L2 (red) and L3 (green). Passage 2 cells 
were used. Abbreviations: LeX, Lewis-X; nMDS, non-metric multi-
dimensional scaling. This work was done in collaboration with Chen Jinmiao 







































Figure 4.8 Heatmap showing the mRNA profile of clusters L1, L2 and L3. 
Heatmap showing the mRNA profile of the different clusters. Each row 
represents one cell and each column represents one gene. Genes under the 
P<0.05 section are genes that show a statistically significant change in 
expression in cluster L1 compared to clusters L2 and L3 combined. Red and 




























Figure 4.9 Genes with significant change in expression in clusters L1, L2 and L3. 
Bar plots showing log2 fold change in gene expression for genes that show significant change in expression (P<0.05) in a cluster 
in comparison with the remaining clusters combined. Panels (A), (B) and (C) show bar graphs for cluster L1, L2 and L3 


































Figure 4.10 Distribution curves reflecting the likelihood of obtaining clusters with specific 
LeX+ve CD93+ve to LeX+ve CD93-ve cells ratio.  
(A) Single-cell mRNA data from passage 2 LeX+ve CD93+ve and LeX+ve CD93-ve cells was 
pooled and 100 cells (number of cells in cluster L1) were randomly selected to form a cluster 
and the ratio of LeX+ve CD93+ve to LeX+ve CD93-ve cells was calculated. This procedure was 
repeated 1000 times to construct the distribution curve. Values 0.75 and 1.33 on the x-axis 
are the boundaries at 90% significance level. Similarly, distribution curves for (B) cluster L2 
and (C) cluster L3 were also constructed. The boundaries at 90% significance level for 
cluster L2 are at 0.72 and 1.39 and for cluster L3 are at 0.83 and 1.21. The ratios for clusters 
L1, L2 and L3, 4.26, 0.64 and 0.57 respectively, indicate that these clusters are not formed by 
chance.  Abbreviations: LeX, Lewis-X. This work was done in collaboration with Chen 






























5 RESULTS: CHARACTERIZATION OF NEURAL STEM CELLS 
5.1 Enrichment of neural stem cells from LeX+ve CD93+ve population 
To investigate the mRNA profile of NSCs in greater detail, I tried to 
further enrich the LeX+ve CD93+ve population for NSCs. In order to obtain a 
significant enrichment of NSCs from the LeX+ve CD93+ve population, it is 
critical to enrich the NFU. Surface expression of three proteins, expression of 
Hes1, addition of CSPG and ApoE to the neurosphere growth medium and 
phase intensity of cells were used to attempt to enrich the NFU in the LeX+ve 
CD93+ve population. 
5.1.1 Notch1, EGFR and CXCR4 do not increase neurosphere 
formation in LeX+ve CD93+ve population  
Notch1 [132, 251], EGFR [92, 93, 120, 252] and CXCR4 [137] have 
been reported to play important roles in NSC function and behavior. I used 
FACS to isolate cells which had high surface expression of Notch1 (Figure 
4.2E), EGFR (Figure 4.4E) or CXCR4 in the LeX+ve CD93+ve population and 
cultured the cells for one week to form neurospheres. Sorting for cells with 
high surface expression of Notch1, EGFR or CXCR4 did not significantly 
enrich the NFU in the LeX+ve CD93+ve population at clonal density (1 
cell/well) (Figure 5.1).  
5.1.2 High Hes1 expression does not increase neurosphere formation in 
LeX+ve CD93+ve population  
Hes1 is one of the effector proteins of the Notch signalling pathway 
and has been demonstrated to promote NSC proliferation and self-renewal 
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while repressing NSC differentiation [183-187]. I investigated whether high 
Hes1 expression could enrich the NFU in the LeX+ve CD93+ve population. 
Primary brain cells from E14.5 Hes1-GFP mice were isolated and GFP 
expression was analyzed over one week in culture. After two days in culture, 8 
± 0.47% of cells showed Hes1 expression and some cells had higher Hes1 
expression than others (Figure 5.2A and 5.2B). However at Day 4 in culture, 
only 2.58 ± 1.51% of cells expressed Hes1 (Figure 5.2A and 5.2B). There was 
an increase in Hes1 expression at Day 5 in culture with 7.50 ± 0.56% Hes1-
GFP- expressing cells before dropping back at Day 7 with 3.40 ± 0.29% Hes-
1-GFP- expressing cells (Figure 5.2B). Hence, Hes1 expression seems to 
oscillate over time in culture, corroborating with a previous finding [262].  
Generally, the primary cells also had higher Hes1 expression compared 
to cells which have been passaged once indicating that passaging dilutes out 
Hes1-expressing cells or weakens Hes1 expression (Figure 5.2B). Therefore, 
passaging Hes1-GFP cells was avoided and primary cells were used for the 
subsequent experiment. 
I sorted LeX+ve CD93+ve Hes1+ve cells by FACS and analyzed their 
neurosphere forming potential at clonal density (1 cell/well) after one week in 
culture (Figure 5.3). Hes1+ve cells had a 2.44-fold higher NFU than the 
unsorted cells indicating that Hes1 expression could enrich for NSCs in the 
unsorted population. However, LeX+ve CD93+ve Hes1+ve and LeX+ve CD93+ve 
Hes1-ve cells had similar NFU as compared to LeX+ve CD93+ve cells suggesting 




5.1.3 CSPG and ApoE do not increase neurosphere formation in LeX+ve 
CD93+ve population 
It is possible that addition of factors which promote neurosphere 
formation or NSC survival, into the neurosphere growth medium could enrich 
the NFU in LeX+ve CD93+ve population. Recent studies have identified 
autocrine/paracrine factors CSPG and ApoE as components of the neurosphere 
conditioned medium [120, 121]. CSPG maintains the three-dimensional 
structure of neurospheres and promotes the survival of NSCs and ApoE 
enhances neurosphere formation and NSC survival. 
Here I added 50µg/ml CSPG and/or 50nM ApoE to the neurosphere 
growth medium and cultured LeX+ve CD93+ve cells at clonal density (1 
cell/well) over one week. The concentrations of CSPG and ApoE used are 
optimal for neurosphere formation and NSC survival [120, 121]. In the 
unsorted population, CSPG and ApoE enhanced neurosphere formation 1.76-
fold and 2.24-fold respectively (Figure 5.4A). When used in combination, 
CSPG and ApoE enhanced neurosphere formation 1.70-fold in the unsorted 
population. However, in the LeX+ve CD93+ve population, neither CSPG nor 
ApoE significantly enhanced formation of neurospheres even in combination. 
 In the unsorted population, CSPG and ApoE did not have a significant 
effect on neurosphere size (Figure 5.4B). In the LeX+ve CD93+ve population, 
CSPG increased neurosphere size while ApoE did not. This demonstrates that 
CSPG and ApoE does not enrich for NSCs in the LeX+ve CD93+ve population 





































































Figure 5.1 Neurosphere forming potential of Notch1+ve, EGFR+ve and CXCR4+ve cells within 
the LeX+ve CD93+ve population. 
Neurosphere-forming potential expressed as NFU relative to that of LeX+ve CD93+ve 
population. NFA was done over one week at clonal density (1 cell/well of 96-well plate) 
(mean ± SD; n = 4; ***P≤0.001). Abbreviations: EGFR, epidermal growth factor receptor; 





































Figure 5.2 Expression of Hes1 over time in culture and passage number. 
(A) Images of primary Hes1-GFP neurospheres grown in culture. Scale bar = 
60 µm. Image was taken with a 10x objective under brightfield and GFP 
channels. (B) Percentage of Hes1-GFP+ve cells over 7 days in primary culture 
and culture that has been passaged once (mean ± SD; n = 4). Abbreviations: 
DIC, differential interference contrast; GFP, green fluorescence protein. 






















































Figure 5.3 Neurosphere forming potential of Hes1+ve cells within the unsorted and 
LeX+ve CD93+ve population. 
Neurosphere-forming potential expressed as NFU relative to that of LeX+ve CD93+ve 
population. NFA was done over one week at clonal density (1 cell/well of 96-well 
plate) (mean ± SD; n = 4; ***P≤0.001). Abbreviations: LeX, Lewis-X; NFU, 




















Figure 5.4 Effect of CSPG and ApoE on neurosphere formation and neurosphere size in 
unsorted and LeX+ve CD93+ve population. 
Unsorted and LeX+ve CD93+ve cells were treated with 50µg/ml CSPG and/or 50nM ApoE and 
cultured at clonal density (1 cell/well of 96-well plate) over one week. (A) Neurosphere-
forming potential expressed as NFU relative to that of untreated LeX+ve CD93+ve population 
(mean ± SD; n = 4; ***P≤0.001). (B) Average neurosphere diameter for the different 
treatments (mean ± SD; n ≥ 29; **P≤0.01). Abbreviations: CSPG, chondroitin sulfate 



























































































































































5.1.4 A pure neural stem cell population isolated from LeX+ve CD93+ve 
population using phase intensity 
It was observed that when visualized using phase-contrast microscopy, 
neurosphere cells have a luminous halo surrounding the cell membrane. The 
halos of some cells are brighter causing these cells to have higher phase 
intensity than the other cells (Shvetha Sankaran and Sohail Ahmed, 
unpublished data). Strikingly, all cells within the LeX+ve CD93+ve population 
with phase intensity of >240 grey values formed tripotent neurospheres, 
indicating a pure NSC population (Shvetha Sankaran and Sohail Ahmed, 
unpublished data). These cells are termed as LeX+ve CD93+ve phase bright 
(Phbrt+ve) cells. The LeX+ve CD93+ve Phbrt+ve cells are a suitable population to 
investigate the mRNA profile of NSCs. 
5.2 Single-cell mRNA profiling of LeX+ve CD93+ve Phbrt+ve cells  
I profiled the mRNA levels of 48 genes (Table 3.1) in single cells of 
LeX+ve CD93+ve Phbrt+ve and unsorted populations both from passage 2 
neurospheres. A total of 48 LeX+ve CD93+ve Phbrt+ve and 43 unsorted cells 
were profiled. The average expression level of each of the 48 genes were 
compared between the LeX+ve CD93+ve Phbrt+ve and unsorted population. 20 
genes showed a significant change in expression level in the LeX+ve CD93+ve 
Phbrt+ve population compared to the unsorted population (Figure 5.5A). A 
heatmap was constructed to visualize the mRNA levels of these 20 genes in 
the LeX+ve CD93+ve Phbrt+ve and unsorted population (Figure 5.5B). 
Genes involved in Notch and Shh signalling pathways, two major 
pathways that govern NSC function [263], were expressed at a higher level in 
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LeX+ve CD93+ve Phbrt+ve than in unsorted cells. Specifically, Jag1, Notch1 and 
Dll1 from the Notch pathway and Gli1 from the Shh pathway were expressed 
at a higher level in LeX+ve CD93+ve Phbrt+ve cells. Musashi1, a known NSC 
marker [264, 265], and Pax6, which is expressed during early neural 
development [65], were also expressed at a higher level in LeX+ve CD93+ve 
Phbrt+ve cells. c-kit, an established marker for HSCs [266, 267], was the most 
highly expressed gene in LeX+ve CD93+ve Phbrt+ve compared to unsorted cells. 
Interestingly, HMGA2, a gene shown to promote self-renewal of mouse fetal 
NSCs was expressed at a lower level in LeX+ve CD93+ve Phbrt+ve cells [39]. 
I checked the in vivo expression of a selected number of genes 
described in the mRNA profile of LeX+ve CD93+ve Phbrt+ve cells. Images of in-
situ hybridization staining of Notch1, Pax6, Sox6, Tead2, POU3F3, REST and 
HMGA2 in E15.5 mouse brain were obtained from the Allen Developing 
Mouse Brain Atlas (http://developingmouse.brain-map.org) (Figure 5.6). 
Notch1, Pax6, Sox6, Tead2, POU3F3 and REST had strong expression while 
HMGA2 showed little or no expression in the VZ/SVZ where NSCs reside. 
For these selected genes, the in vivo labelling profile corroborates with the 




 Figure 5.5 Genes with significant change in expression in LeX+ve CD93+ve 
Phbrt+ve cells compared to unsorted cells. 
(A) Bar plots showing log2 fold change in gene expression for genes that show 
significant change in expression (P<0.05) in LeX+ve CD93+ve Phbrt+ve cells 
compared to unsorted cells. (B) Heatmap showing the mRNA profile of 
LeX+ve CD93+ve Phbrt+ve and unsorted cell. Each row represents one cell and 
each column represents one gene. Genes which have a statistically significant 
change in expression (P<0.05) in LeX+ve CD93+ve Phbrt+ve compared with 
unsorted cells are shown. Red and green colours represent high and low 
expression respectively. Abbreviation: LeX, Lewis-X; Phbrt, phase bright. 
This work was done in collaboration with Shvetha Sankaran (Institute of 


























Figure 5.6 In vivo expression of genes described in the mRNA profile of LeX+ve CD93+ve Phbrt+ve cells. 
Images were obtained from the Allen Developing Mouse Brain Atlas; cited on 1st May 2013; available from 
http://developingmouse.brain-map.org/. (A) – (G) show in situ hybridization staining of selected genes described in the mRNA 
profile of LeX+ve CD93+ve Phbrt+ve cells. E15.5 mouse brain cortices were stained with digoxygenin-labeled probe targeting the 
selected mRNAs. Nuclei were counterstained yellow with Feulgen-HP DNA stain. Arrowheads label VZ/SVZ. Note the strong 
staining of Notch1, Pax6, Sox6, Tead2, POU3F3, REST and lack of staining of HMGA2 in the VZ/SVZ. Scale bar = 615µm. 
Abbreviations: LV, lateral ventricle; LeX, Lewis-X; Phbrt, phase bright; E, embryonic day; VZ, ventricular zone; SVZ, 
subventricular zone. 
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NSCs are undifferentiated cells of the CNS which have the ability to 
self-renew and differentiate into the three major neural lineages – astrocytes, 
oligodendrocytes and neurons. NSCs occur throughout CNS development and 
exist in specific locations in the adult brain. The study of NSC biology is 
critical for understanding neurodevelopment and developing treatments for 
neurological diseases. Pioneering works of Reynolds and Weiss during the 
early 1990s demonstrated that NSCs and NPs can be cultured in vitro as free-
floating structures known as neurospheres [75, 92, 93]. Since then, the 
neurosphere culture system has been widely used to propagate and investigate 
NSCs and NPs.  
Although neurospheres have been used to study NSCs and NPs for 
over 20 years, we still do not have a clear understanding of this culture system. 
Specifically, the exact cell types present within neurospheres are unknown. 
Moreover, the genes and signalling pathways which specify and control the 
cell types warrant investigation. The neurosphere culture system consists of a 
heterogeneous mix of cells but only certain cells harbor the unique ability to 
form neurospheres or function as an NSC. To date, the identity of an NFC and 
NSC in vitro remains elusive.  The genes and signalling pathways crucial for 
the function and behavior of NFCs and NSCs are not fully understood. 
Furthermore, due to a lack of specific NSC markers, it remains a challenge to 
distinguish NSCs from NPs in vitro.  
In this section, I discuss how single-cell mRNA profiling is used to 
identify the progenitor subclasses present in neurospheres and show how this 
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finding supports the use of neurospheres to model CNS development. I then 
examine the genes which specify and control transition of these subclasses. I 
go on to identify and describe the mRNA profiles of NFCs, NSCs, 
bi/unipotent NPs and non-NFCs. In addition, I discuss how specific genes and 
mechanisms contribute to the manifestation of the characteristics and behavior 
of NFCs, NSCs and NPs. Finally, I discuss how single-cell mRNA profiling 
can be used to distinguish NSCs from NPs in vitro and help identify novel 
genes and signalling pathways crucial for NSC function. 
6.1 Progenitor subclasses in neurospheres 
6.1.1 Neurospheres consist of three progenitor subclasses which follow a 
developmental timeline of early, intermediate and late 
Neurospheres consist of a heterogeneous mix of cells [95, 98, 268]. 
However, the exact cell types present in the neurosphere culture system is 
unclear. Single-cell mRNA profiling allows one to study the expression of 
genes of interest in individual cells. Hence, variation among cells could be 
detected and enables one to uncover subpopulations within a heterogeneous 
system. Thus I used single-cell mRNA profiling to investigate the cell types 
present within neurospheres. 
Previously, Kawaguchi et al. performed single-cell mRNA profiling on 
primary cells directly derived from the embryonic mouse brain to explore the 
cell types present in vivo [239]. They identified three progenitor subclasses – 
the apical, young basal and basal progenitors. The apical progenitors are stem-
like cells with radial-glial morphology and reside in the VZ. The young basal 
progenitors are daughter cells of the apical progenitors and also reside in the 
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VZ. The apical and young basal progenitors are undifferentiated and are at an 
early developmental stage. During the course of development, the young basal 
progenitors migrate to the SVZ and give rise to the basal progenitors. The 
basal progenitors are committed to differentiating into neurons and thus are at 
a late developmental stage. 
I performed single-cell mRNA profiling on E14.5 mouse neurospheres. 
E14.5 neurospheres were used since the highest NSC activity occurs at this 
stage near the peak of neurogenesis as described in section 1.4. I was able to 
delineate three clusters – US1, US2 and US3. This indicates that there are at 
least three progenitor subclasses present in neurospheres. Furthermore, I 
observed striking similarities between the mRNA profiles of the subclasses in 
neurospheres and those in primary brain cells, studied by Kawaguchi et al 
[239]. Both cluster US1 and the apical/young basal cells had high expression 
level of Hes5, Musashi1, FGFR2, BLBP, Notch1, Gli2 and Dll1. Cluster US1 
also showed high expression of Bmi1, POU3F2 and Prominin1. All these 
genes have been implicated in NSC self-renewal and proliferation and help 
maintain cells in their early, undifferentiated state. This suggests that cluster 
US1 consists of early progenitors.  
Both cluster US3 and the basal progenitors had low expression level of 
Hes5, Pax6 and BLBP. The expression of Pax6 has been shown to decline 
through development [65]. Moreover, the mRNA profile of cluster US3 seems 
to be the opposite of cluster US1. This suggests that cluster US3 consists of 
late progenitors. Cluster US2 adopted expression patterns of both clusters US1 
and US3 and thus seems to be an intermediate cluster. Taken together, the 
three progenitor subclasses in neurospheres follow a developmental timeline 
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of early, intermediate and late progenitors. This finding makes this study the 
first to show the cellular makeup of neurospheres. 
Contrasting observations were made in a recent study where single-cell 
mRNA profiling on neurospheres derived from adult mouse brain did not 
derive any subpopulation [269]. However, it has to be noted that the authors 
only profiled 11 genes and most of the genes were associated with astrocytes 
rather than NSCs/NPs for reasons of focus. Hence, the choice of genes may be 
a reason why no subpopulations were detected in the neurospheres. It could 
also be possible that the three progenitor subclasses in the embryonic brain do 
not persist in the adult brain. 
In my clustering analysis, majority (65.6%) of cells in neurospheres are 
intermediate progenitors while only a small proportion (9.7%) of cells are 
early progenitors. Late progenitors make up 24.7% of cells. A possible reason 
for this observation is that the rate of transition from early to intermediate 
stage is more rapid than the rate of transition from intermediate to late stage, 
causing accumulation of intermediate progenitor cells. 
6.1.2 Neurospheres as a model for CNS development 
I showed that the three progenitor subclasses present in neurospheres 
are similar to those found in vivo in terms of developmental timeline. This 
suggests that the neurosphere culture system reflects CNS development and 
thus could be used to model it. The use of neurospheres to model CNS 
development is further supported by observations made during neurosphere 
differentiation. The sequence of cell type emergence in differentiating 
neurospheres reflects the sequence that occurs during CNS development. 
Neurons are usually located towards the outside of the neurosphere, followed 
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by oligodendrocytes and then astrocytes which mainly reside within the 
neurosphere [270]. 
The revelation of the three progenitor subclasses in neurospheres 
promotes the use of neurospheres to address areas on CNS development that 
require clearer understanding. For instance, the early, intermediate and late 
progenitors could be used to further explore the gene regulatory networks that 
specify each developmental stage of cells. In addition, how changes in 
particular genes result in progression of cells from the early to intermediate to 
late progenitors could also be investigated. This would lead to a better 
understanding on how different progenitor subclasses are specified and 
maintained during CNS development. Moreover, whether the three progenitor 
subclasses and expression of their signature genes occur in specific regions 
within the neurosphere and how well it relates with the regional specification 
of the in vivo subclasses would be interesting points to address.  
The use of neurospheres to model CNS development has its 
advantages. Investigating CNS development using in vivo systems often 
involves challenges in terms of generation of model organisms, time and 
technical limitations. On the other hand, neurospheres are relatively easy to 
propagate and have a short doubling time of 24 hours [120]. In addition, 
genetic manipulations and common experimental techniques such as 
transfection and viral transduction can be performed on neurospheres. This 
allows neurospheres to circumvent the difficulties encountered with in vivo 
systems.  
Furthermore, neurospheres can be used to complement in vivo studies, 
particularly those investigating the role of intrinsic factors during the 
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progression from early to late CNS development. Where extrinsic factors 
provided by the physiological environment are critical, the neurospheres can 
be cultured in medium containing precise concentrations of these factors or 
co-cultured with other cell types. However, one still has to exercise caution 
when using observations made in neurospheres to draw conclusions about 
CNS development since cell-cell interactions which are normally present in 
the physiological environment may be limited in the neurosphere culture 
system.  
6.1.3 Loss of Notch signalling converts early progenitors to intermediate 
and then to late progenitors 
I observed that the early progenitors had high expression of genes 
involved in Notch signalling pathway such as Notch1, Hes5, Musashi1, Dll1 
and Dll3, indicating active Notch signalling in these cells. The intermediate 
progenitors lost high Notch1 expression, suggesting that these cells are less 
receptive to extracellular activators of the Notch pathway which would lead to 
less active Notch signalling. The late progenitors had low expression of the 
Notch effector Hes5 and did not have high expression of the other Notch 
pathway-associated genes, indicating that Notch signalling is least active in 
these cells. Hence, there seems to be a progressive loss of Notch signalling as 
cells transit from early to intermediate to late progenitors. Perhaps Notch 
signalling is critical for maintenance of early progenitors and loss of Notch 
signalling converts early progenitors to intermediate and late progenitors. This 
agrees well with the in vivo observation that loss of Notch signalling converts 
apical progenitors to basal progenitors [239]. 
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6.1.4 Bmi1, Hes5, Klf12 and Myc determine the developmental stage of 
neurosphere cells 
The genes which showed the highest change in expression between the 
early and late progenitors are Bmi1, Hes5, Klf12 and Myc. Previous studies 
have shown that Bmi1 and Hes5 are important for NSC self-renewal, 
proliferation and repression of differentiation [183, 184, 240-244]. Thus, high 
expression of Bmi1 and Hes5 maintains cells in their early developmental 
stage. This corroborates well with my data as loss of expression of these two 
genes led to maturation of early progenitors to late progenitors. 
Klf12 encodes a transcription factor which has been reported to play a 
role in neural tube development by repressing AP-2 alpha protein expression 
[271, 272]. The early progenitors had low expression of Klf12 and perhaps a 
high expression of AP-2 which could in turn maintain the cells in their early 
developmental stage. Myc encodes a transcription factor which has been 
shown to regulate neural precursor cell cycle, cell fate and metabolism [273, 
274]. The expression of Myc increased from early to late progenitors, 
suggesting that Myc could promote maturation of early progenitors to late 
progenitors. This is further supported by a study that demonstrated that 
specific mature neuronal subtypes were absent in brains from Myc knockout 
mice [273]. Taken together, I propose that the expression levels of Bmi1, 
Hes5, Klf12 and Myc determine whether a neurosphere cell is an early or a late 
progenitor in vitro.  Interestingly, it could be possible that these four genes 
may regulate each other’s expression to determine the developmental stage of 
the cell.  
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6.2 Cells with increased cell size and granularity are enriched for 
neurosphere-forming cells  
I next wanted to identify an NFC cluster. The NFC frequency in the 
unsorted population is only 14.6%. Hence, it would be difficult to detect an 
NFC cluster by single-cell mRNA profiling and clustering of the unsorted 
population. I sought a method to enrich for NFCs. Previous studies have used 
four main methods to enrich for NFCs - (i) exclusion of Hoechst 33342 dye 
[114]; (ii) surface markers such as CD133/Prominin1 [129], LeX [112, 126], 
syndecan-1, Notch-1 and integrin-beta1 [132]; (iii) cell size and granularity 
[113, 154]; (iv) addition of NSC survival factors such as CSPG and ApoE 
[120, 121]. I decided to use cell size and granularity to enrich for NFCs as it is 
the only method that does not involve treatment of cells with dyes, antibodies 
or additional factors, hence preserving the integrity of the cells. 
When cells are sorted by FACS, larger cells have a higher forward 
scatter than smaller cells and more granular cells have a higher side scatter 
than less granular cells. Thus, larger and more granular cells were isolated by 
gating the FSC/SSC high cells. The FSC/SSC high cells had two- to three- fold 
higher neurosphere formation potential than FSC/SSC low and unsorted cells, 
indicating that the FSC/SSC high population is enriched for NFCs. Through 
time-lapse imaging, it was observed that bigger cells tend to form more 
neurospheres. This suggests that the increased average cell size of the 
FSC/SSC high population partly contributes to its higher neurosphere formation 
potential compared to the FSC/SSC low population.  
155 
 
6.3 Cells with increased cell size and granularity are enriched for 
neural stem cells  
The FSC/SSC high population had higher surface expression of 
phosphacan and LeX, higher proliferation capacity, self-renewal capacity and 
tripotency than the FSC/SSC low and unsorted population, indicating 
enrichment of NSCs. 
Enumeration of NSC frequency is necessary to confirm enrichment of 
NSCs in the FSC/SSC high population. In recent studies, NSC frequency was 
calculated as a product of NFU and percentage of tripotent neurospheres under 
clonal conditions and I adopted this method for NSC enumeration [120, 121].  
It is critical to enumerate NSCs under clonal conditions where each 
neurosphere arises from a single cell and these clonal neurospheres are 
evaluated for tripotency. In bulk culture conditions, aggregation of both single 
cells and neurospheres occur [122-124]. Thus each neurosphere under bulk 
culture conditions could arise from multiple cells or neurospheres and are not 
clonal. This undermines the accuracy of the NFU and tripotency. Here I 
performed NFA and multipotency assay under clonal conditions and found 
that besides being enriched for NFCs, the FSC/SSC high population is also 
enriched for NSCs (~4.3-fold) compared to the FSC/SSC low population. This 
is in agreement with previous studies that show that cell size and granularity 
enrich for NSCs [113, 154]. The reason why cells with larger size and 
granularity are enriched for NSCs is not clear although some explanations 
could be offered. NSCs would require several cellular processes such as 
transcription, translation, intracellular trafficking and metabolism of 
biomolecules to enable self-renewal, proliferation and repression of 
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differentiation. Thus, presence of all the factors involved in these processes 
within the cell could lead to higher granularity. A larger cell volume is also 
required to contain all the factors driving vital processes in NSCs, hence 
leading to larger cell size. In addition, NSCs could expand in size during cell 
division which could contribute to their larger cell size. 
6.4 Identification of neurosphere-forming cells 
6.4.1 mRNA profile of neurosphere-forming cells indicates their 
proliferative nature   
Single-cell mRNA profiling and clustering of FSC/SSC high and 
FSC/SSC low cells obtained three clusters – S1, S2 and S3. Three parameters 
were calculated for each cluster - the ratio of FSC/SSC high to FSC/SSC low 
cells, the percentage of total FSC/SSC high cells and the percentage of total 
FSC/SSC low cells in the cluster. By comparing these values with the expected 
values of the same three parameters for an NFC cluster, I propose cluster S1 to 
be the NFC cluster. 
The mRNA profile of cluster S1 revealed that these cells are highly 
mitogen- responsive as they express high levels of growth factor receptors 
such as FGFR1, FGFR2 and EGFR. Cluster S1 also showed high expression 
level of the Notch effectors Hes1 and Hes5. Studies have shown that knockout 
of Hes1 and Hes5 led to smaller neurospheres [184] and knockdown of Hes1 
impaired cell division in neurospheres as indicated by decreased BrdU 
incorporation [186]. In addition, overexpression of Hes1 stimulated 
proliferation of NPs in vitro [187]. These studies clearly establish the role of 
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Hes1 and Hes5 in NSC/NP proliferation. Thus high expression of Hes1 and 
Hes5 in cluster S1 is indicative of its high proliferative capacity.  
Sonic Hedgehog signalling-related genes Gli1 and Gli2 were also 
highly expressed in cluster S1. Knockdown of Gli1 reduced proliferation of 
hippocampal neurospheres [210] while overexpression of Gli1 resulted in 
bigger brains and increased the NSC/NP population [209]. Similarly, knockout 
of Gli2 led to reduced VZ/SVZ volume, decreased number of proliferative 
cells in the embryonic brain and smaller neurosphere size in vitro [215]. In 
addition, overexpression of a mutant form of Gli2 blocked proliferation of 
neuroepithelial cells in vivo and in vitro [212]. Hence Gli1 and Gli2 are crucial 
for NSC/NP proliferation and increased expression of Gli1 and Gli2 suggest 
that cluster S1 cells are highly proliferative. Taken together, high expression 
of growth factor receptors, Hes1, Hes5, Gli1 and Gli2 allows cluster S1 cells 
to proliferate and initiate the formation of neurospheres and thus function as 
NFCs. 
6.4.2 Early progenitor subclass is the cell population that gives rise to 
neurospheres 
The mRNA profile of cluster S1, the NFCs, most closely matched that 
of cluster US1, the early progenitor subclass. This strongly suggests that early 
progenitor cells are the cell population that gives rise to neurospheres. It was 
previously thought that only NSCs could form neurospheres. More recently, 
there are suggestions that some NPs also have the ability to give rise to 
neurospheres [111]. However, the exact nature of NFCs is still poorly 
understood. Here I have shown that NFCs belong to the early progenitor 
subclass which consists of both NSCs and early NPs. This reaffirms that both 
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NSCs and some NPs, specifically early NPs, could give rise to neurospheres. 
This provides crucial information on the identity of the cells for future studies 
involving embryonic neurosphere formation. However, the identity of the 
NFCs in neurosphere cultures derived from adult tissue or other mammalian 
systems remains to be investigated. 
A few reasons could account for why only early progenitors give rise 
to neurospheres. First, compared to the intermediate and late progenitors, early 
progenitors show higher expression of Bmi1, Hes5, FGFR2, Gli1 and Gli2, all 
of which promote NSC/NP proliferation (reviewed in [263]). High 
proliferation capacity of early progenitors facilitates neurosphere formation. 
Second, it could be possible that early progenitors secrete more ECM 
molecules such as laminins and CSPGs than intermediate or late progenitors. 
This mediates formation of a rich ECM which provides structural support for 
neurosphere formation. Third, neurosphere cells undergo changes in karyotype 
as they are cultured over several passages (Fenggang Yu, unpublished). A 
similar effect could occur as cells transit from early to intermediate to late 
developmental state. Whether changes in karyotype compromise neurosphere 
formation is yet to be explored. However, it could be possible that early 
progenitors maintain their karyotype better than intermediate and late 
progenitors, which in turn helps to retain the ability to form neurospheres. 
6.5 LeX+ve CD93+ve and LeX+ve CD93-ve cells are enriched for neural 
stem cells 
I next sought to identify an NSC cluster. The NSC frequency in the 
FSC/SSC high population is not sufficiently high to be used to identify an NSC 
cluster. Thus, a population further enriched for NSCs had to be derived. 
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Various studies have proposed ways to enrich for NSCs [113, 114, 132, 154]. 
However, the method for enumerating NSC enrichment differs in these 
studies. Some studies solely use neurosphere formation [112-114]. 
Determining NSC enrichment only by neurosphere formation is inaccurate as 
both NSCs and some NPs are able to form neurospheres [111]. Other studies 
use neurosphere formation and tripotency to determine NSC enrichment [154]. 
However it is unclear whether clonality was maintained when assessing 
neurosphere formation and tripotency. For these reasons, the extent of NSC 
enrichment using these methods is not certain. Thus I did not use these 
methods for NSC enrichment.  
LeX+ve CD93+ve and LeX+ve CD93-ve populations have an NSC 
frequency of 45.86% and 10.32% respectively (Mike Yu and Sohail Ahmed, 
unpublished). Both populations are enriched for NSCs compared to the 
FSC/SSC high population. The LeX+ve CD93+ve population also had higher 
expression of Notch1, Dll1, EGFR, CXCR4 and Hes1 than the unsorted 
population, confirming enrichment of NSCs. Thus I selected the LeX+ve 
CD93+ve and LeX+ve CD93-ve population to identify an NSC cluster. 
6.6 Identification of neural stem cells and neural progenitors 
6.6.1 Single-cell mRNA profiling identifies neural stem cells, 
bi/unipotent neural progenitors and non-neurosphere-forming 
cells in neurospheres 
I performed single-cell mRNA profiling on LeX+ve CD93+ve and 
LeX+ve CD93-ve cells in the aim of finding an NSC cluster. I was able to derive 
three clusters – L1, L2 and L3. Two parameters were calculated for each 
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cluster - the ratio of LeX+ve CD93+ve to LeX+ve CD93-ve cells and the 
percentage of total cells falling in the cluster. By comparing these values with 
the expected values of the same two parameters for an NSC, bi/unipotent and 
non-NFC cluster, I propose clusters L1, L2 and L3 to be the NSC, bi/unipotent 
and non-NFC cluster respectively. Hence through clustering analysis the NSCs 
are distinguished from the other types of NPs and the NSC mRNA profile can 
be investigated. This effectively bypasses the need for a specific NSC marker 
to isolate NSCs to purity before studying their mRNA profile.  
6.6.2 mRNA profile of neural stem cells indicate high self-renewal and 
proliferative capacity and repression of differentiation 
The mRNA profile of the NSC cluster revealed high expression of 
genes involved in Notch signalling such as Notch1, Jag1, Hes1 and Hes5, 
genes involved in Shh signalling such as Gli2 and genes involved in growth 
factor signalling such as FGFR1 and FGFR2. The Notch, Shh and growth 
factor signalling pathways have established roles in NSC function and 
behavior (reviewed in [263]). Hes1, Hes5 and Gli2-knockout cortical cells 
have limited ability to passage in culture showing that Hes1, Hes5 and Gli2 
play a role in NSC self-renewal [184, 185, 215]. High expression of these 
genes in the NSC cluster reaffirms that these cells fulfill one of the 
characteristics of NSCs - the ability to self-renew. 
The mRNA profile of the NSC cluster also suggests that these cells are 
highly proliferative. Cells in the NSC cluster express high levels of Hes1, 
Hes5 and Gli2, all of which are known to be involved in NSC proliferation 
[184, 186, 187, 212, 215]. Furthermore, these cells show high expression of 
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FGFR1 and FGFR2, suggesting that these cells are receptive to extracellular 
mitogens which promote proliferation. 
The NSC cluster showed low expression of Sox6, Sox9 and Olig1. All 
three genes are involved in oligodendrocyte specification and are highly 
expressed in oligodendrocyte precursor cells [144, 261, 275]. This suggests 
that cells in the NSC cluster are not committed to differentiation. Hes1 and 
Hes5 are known to repress differentiation as RGCs in Hes-deficient embryos 
prematurely differentiate into neurons [183]. High expression of Hes1 and 
Hes5 and low expression of Klf12 (which I earlier established as a late 
developmental marker in section 7.1.4) in the NSC cluster strongly indicate 
that these cells are undifferentiated, another feature of NSCs. 
RGCs reside in the VZ of the developing brain and together with the 
neuroepithelial cells, form the NSC pool in vivo (reviewed in [276]). Cells in 
the NSC cluster showed high expression level of two RGC markers, GLAST 
and BLBP [165, 171]. This suggests that NSCs in neurospheres and NSCs in 
vivo have similar expression patterns of specific NSC markers.  
One discrepancy observed is that cells in the NSC cluster showed low 
expression of Nestin, Sox2 and Prominin1 which have been reported to be 
NSC markers [130, 153, 172]. To explain this discrepancy, it is important to 
examine the evidence that proposes Nestin, Sox2 and Prominin1 to be NSC 
markers. First, Nestin and Prominin1 are shown to enrich for NSCs [130, 172] 
but do not enrich to purity. In addition, not all cells expressing these markers 
were able to form neurospheres, let alone multipotent ones. Hence NPs could 
also express these genes. This is supported by the evidence that Nestin 
staining occurs in the SVZ (although to a lesser extent as compared to the VZ) 
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where NPs reside [172]. Second, although it is shown that all neurospheres 
derived from Sox2-expressing cells are multipotent, it is not clear whether the 
neurospheres were cultured and differentiated under clonal conditions [153]. 
For these reasons, NSCs may not necessarily have a higher expression of 
Nestin, Prominin1 and Sox2 than NPs in neurospheres. 
6.6.3 Notch1-Dll1 mediated lateral inhibition could be present in 
neurospheres 
The expression pattern of components of the Notch signalling pathway 
strongly suggests the presence of lateral inhibition in neurospheres. Lateral 
inhibition is a mechanism that controls developmental fates of individual cells 
according to the state of neighbouring cells. Lateral inhibition is involved in 
the generation of different cell types in the inner ear and segmentation of 
mesoderm into somites during formation of skin appendages [143].  
The NSC cluster showed high expression of Notch1, a Notch signalling 
receptor, and Hes1 and Hes5, Notch signalling effectors. Strong Notch 
signalling enables the NSCs in neurospheres to maintain high self-renewal and 
proliferative capacity and to remain undifferentiated. Strikingly, the NSC 
cluster showed a low expression level of Dll1, a Notch signalling ligand. 
Hence the NSCs have a low surface expression of Dll1, resulting in the NPs 
immediately surrounding the NSCs to receive low Dll1 signal. This in turn 
leads to weak Notch signalling in the NPs which results in loss of self-renewal 
and proliferative capacity and less repression of differentiation. In essence, 
this mechanism enables NSCs to maintain their population while inhibiting 
surrounding NPs to have NSC characteristics.  
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6.6.4 Distinguishing neural stem cells, bi/unipotent neural progenitors 
and non-neurosphere-forming cells in neurospheres 
The distinction between NSCs and NPs in neurospheres remains 
unclear. In the nMDS plot, the separation among the NSCs, bi/unipotent NPs 
and non-NFCs did not appear to be very distinct. Rather, the three cell types 
seem to be a continuum. This indicates that although the three cell types can 
be distinguished from each other, the transition from NSCs to bi/unipotent 
NPs to non-NFCs is a progressive one.  
I compared the mRNA profiles of NSCs and bi/unipotent NPs. I 
observed similar patterns of expression in the NSCs and bi/unipotent NPs. For 
instance, both cell types had high expression of radial-glial markers such as 
GLAST and BLBP and genes involved in self-renewal, proliferation and 
repression of differentiation such as Hes1, Hes5, FGFR1 and FGFR2. 
Moreover, both cell types had low expression of Dll1 and Klf12. As NSCs 
develop into bi/unipotent NPs, these similarities could be remnants of NSCs 
that persist in the NPs. These genes could still provide some self-renewal and 
proliferative ability to the bi/unipotent NPs but to a lesser extent compared to 
NSCs. Thus, the bi/unipotent NPs could still form neurospheres but they lack 
the ability to be maintained over several passages. 
Although both NSCs and bi/unipotent NPs are able to form 
neurospheres, NSCs form tripotent neurospheres which self-renew over 
several passages while bi/unipotent NPs form bi/unipotent neurospheres with 
limited self-renewal capacity. These differences could result from the 
difference in Notch1 expression level between NSCs and bi/unipotent NPs. 
From the mRNA profiles, bi/unipotent NPs no longer express high levels of 
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Notch1 unlike NSCs. Loss of Notch1 could reduce the self-renewal ability of 
bi/unipotent NPs and could also lead to the expression of differentiation 
markers such as Sox9 [144] and Myt1l [148, 149] which are involved in 
oligodendrogenesis and neurogenesis respectively. These markers lead to 
commitment of the NPs to specific lineages which in turn results in loss of 
tripotency and establishes bi/unipotent character in these cells. I could not 
further distinguish between bipotent and unipotent NPs. The lack of a vast 
difference in expression level of the genes profiled between bipotent and 
unipotent NPs could account for this observation. 
The mRNA profile of non-NFCs is nearly opposite to that of NSCs. 
This indicates that the non-NFCs lack the ability to self-renew and proliferate 
which explains why these cells cannot generate neurospheres. The non-NFCs 
also have high expression of the late developmental marker Klf12 and the 
differentiation markers Sox6, Olig1 and Mash1 which promote 
oligodendrogenesis and neurogenesis [150-152, 261]. These observations 
suggest that non-NFCs have exited the cell cycle and are probably at later 
stages of differentiation. The factor that prevents these cells to be terminally 
differentiated could possibly be the culture medium which contains growth 
factors and lacks the differentiation-inducing serum. 
6.7 Enrichment of neural stem cells from the LeX+ve CD93+ve population 
Single-cell mRNA profiling of the LeX+ve CD93+ve population has 
allowed me to distinguish NSCs from bi/unipotent NPs and non-NFCs. At that 
point in time, the LeX+ve CD93+ve cells represented the population most 
enriched with NSCs. Studying a pure population of NSCs would provide more 
clues on the gene regulatory networks that define NSCs. Hence, I tried to 
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further enrich for NSCs from the LeX+ve CD93+ve population. I selected cells 
expressing Notch1, EGFR, CXCR4 or Hes1 within the LeX+ve CD93+ve 
population. However, none of the selection methods led to a significant 
increase in neurosphere formation capacity. Even if all neurospheres formed 
using the selection methods were tripotent, the NSC frequency would not be 
significantly higher than that of the LeX+ve CD93+ve population. Hence, I did 
not proceed to check the multipotency of the neurospheres resulting from 
these selection methods. 
A few reasons could account for the lack of enrichment of NSCs. First, 
the chosen markers could be selective rather than specific for NSCs. For 
instance, EGFR is expressed in both NSCs and NPs. Hence, selecting EGFR-
expressing cells in the LeX+ve CD93+ve population would not necessarily mean 
selecting for NSCs. NPs could also be selected leading to a lack of enrichment 
of NSCs. Second, the cells are passed through a pressurized and sub-optimal 
environment during FACS, despite the conditions being adjusted for NSCs. 
This may result in cell damage and poor recovery of cells after FACS which 
could limit neurosphere formation. Third, the components in the NSC growth 
medium could limit neurosphere formation. Therefore I added CSPG and/or 
ApoE, two factors reported to increase NSC survival, to the growth medium 
[120, 121]. However, CSPG and ApoE did not help increase neurosphere 
formation in the LeX+ve CD93+ve population. CSPG and ApoE increase NSC 
survival in the unsorted population via the EGFR and MAPK/ERK signalling 
pathways respectively [120, 121]. It is possible that these pathways are already 
activated to the maximum in the LeX+ve CD93+ve population and thus addition 
of CSPG and ApoE could not further increase neurosphere formation. 
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Meanwhile, it was observed that some cells within the LeX+ve CD93+ve 
population had a brighter “halo” around the cell membrane than other cells 
when imaged using phase contrast microscopy (Shvetha Sankaran and Sohail 
Ahmed, unpublished). Strikingly, these LeX+ve CD93+ve Phbrt+ve cells could all 
form tripotent neurospheres and thus represent a pure NSC population 
(Shvetha Sankaran and Sohail Ahmed, unpublished). The reasons for the 
bright “halo” remain to be investigated although enhanced proteoglycan 
secretion could be a possibility [120, 277]. 
6.8 Characterization of neural stem cells 
I performed single-cell mRNA profiling on LeX+ve CD93+ve Phbrt+ve 
cells which represent a pure NSC population. I found that 20 genes showed 
significant changes in expression between LeX+ve CD93+ve Phbrt+ve and the 
unsorted population. Genes closely associated with NSC function such as 
Notch1, Musashi1, Jag1, Pax6 and Gli1 were highly expressed in the LeX+ve 
CD93+ve Phbrt+ve cells. However, a few discrepancies were observed. Klf12, a 
late developmental marker, and differentiation markers such as Sox6 and 
Mash1 were highly expressed in LeX+ve CD93+ve Phbrt+ve cells compared to the 
unsorted cells. In addition, Dll1 which is expressed at a low level in NSCs due 
to lateral inhibition mechanism was instead expressed at a higher level in 
LeX+ve CD93+ve Phbrt+ve cells. Two possible reasons could account for the 
discrepancies. First, the mRNA profile of LeX+ve CD93+ve Phbrt+ve cells was 
derived based on comparison with the unsorted population which itself 
contains a low percentage of NSCs. Ideally, a population in which NSCs are 
completely absent should be used for comparison. Non- phase bright cells 
within the LeX+ve CD93+ve Phbrt+ve population cannot be used for comparison 
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since it is not clear whether NSCs are absent in this population. Moreover, 
there are no reports of selection methods that isolate a population completely 
void of NSCs. This leaves the unsorted cells to be the best population for 
comparison. Second, isolation of LeX+ve CD93+ve Phbrt+ve cells was performed 
by manual picking which requires a longer time as compared to FACS. The 
longer time for isolation could have caused some loss of mRNA integrity 
leading to the discrepancies observed. 
6.8.1 Neural stem cells in vitro are heterogeneous 
All LeX+ve CD93+ve Phbrt+ve cells are able to form tripotent 
neurospheres. Despite this uniform characteristic, the heatmap for the NSC 
expression data showed that the NSC population is in fact heterogeneous in 
terms of gene expression. How this translates to differences in behavior is an 
interesting question to address. It could be possible that different NSC types 
have varying degrees of self-renewal and proliferative capacity. Also, the 
different types of NSCs could be at different stages of the cell cycle. All 
LeX+ve CD93+ve Phbrt+ve cells could differentiate into astrocytes, neurons and 
oligodendrocytes. However, it could be possible that the different types of 
NSCs could have varying propensity to differentiate into specific lineages. 
6.8.2 Genes crucial for neural stem cell function and behaviour 
The mRNA profile of LeX+ve CD93+ve Phbrt+ve cells identified genes 
which may be crucial for NSC function and behavior. The functions of the 
following genes in the mRNA profile are still unclear and thus are candidates 
for further investigation. 
168 
 
(i) c-kit. I observed that c-kit is a highly expressed gene in the LeX+ve 
CD93+ve Phbrt+ve cells and thus could play crucial roles in NSC function and 
behavior. Previous studies have detected expression of c-kit in mouse 
embryonic neurospheres [278], mouse embryonic cortical cells [279], adult rat 
SVZ and SGZ [279] and in the adult mouse SVZ [278]. c-kit is an established 
surface marker for HSCs [266, 267]. c-kit is the receptor for stem-cell factor 
and elicits a range of signalling pathways such as the RAS/Erk, PI3-Kinase, 
Src kinase and JAK/STAT pathways [280]. Activation of c-kit has been shown 
to increase survival, proliferation and self-renewal of HSCs [281, 282]. It 
could be possible that activation of c-kit leads to similar effects in NSCs. High 
expression of c-kit in NSCs also highlights that NSCs and HSCs are intricately 
linked. This corroborates with reports which show that HSCs and NSCs 
express common genes and antigens [283, 284]. Moreover, surface markers of 
HSCs such as Prominin1 and Syndecan-1 could be used to enrich for NSCs 
[129, 132]. Interestingly, NSCs have been shown to have the potential to 
transdifferentiate into HSCs [285]. 
(ii) BHLHB2. BHLHB2 encodes a transcriptional regulator which has 
a sequence and helix-loop-helix structure similar to the Hes proteins [286]. 
BHLHB2 is involved in regulation of the circadian rhythm [287-295] and 
adipogenesis [296-298]. However, the exact function of BHLHB2 in NSCs is 
yet to be investigated. The effects of BHLHB2 expression in other cell types 
could offer a hint of its possible function in NSCs. It has been reported that 
overexpression of BHLHB2 induces neuronal differentiation in P19 cells 
while repressing mesodermal and endodermal differentiation. This, together 
with evidence that BHLHB2 is expressed in the neuroectoderm [286], 
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suggests that BHLHB2 is required for specification of neuronal lineage during 
development.  
It has been shown that BHLHB2 undergoes post-translational 
sumoylation and the modified BHLHB2 represses cyclin D1 transcription, 
leading to cell cycle arrest in fibroblasts [299, 300]. In addition, BHLHB2 
antagonizes Notch signalling in muscle cells [301]. Similarly in NSCs, it could 
be possible that BHLHB2 promotes cell cycle arrest by repression of cyclin 
D1 and Notch signalling. This could indeed be a regulatory mechanism to 
prevent excessive proliferation of NSCs which could result in tumor 
formation. Studying the effects of disruption of BHLHB2 on NSC proliferation 
and tumor formation would help investigate this proposed function of 
BHLHB2. 
(iii) Tead2. Strong expression of Tead2 in the VZ/SVZ of the 
developing cortex as observed from images from the Allen Brain Atlas 
suggests that NSCs highly express this gene. It has been reported that 
transgenic mice deficient in Tead2 display neural tube defects [302]. However, 
the exact function of Tead2 in NSCs warrants further investigation. Tead2 
expression is negatively regulated by the Hippo signalling pathway. The 
Hippo signalling pathway is well-studied in Drosophila and has been shown to 
inhibit cell proliferation and organ growth [303, 304]. High expression of 
Tead2 in NSCs suggests that the Hippo signalling pathway is curbed in NSCs 
to enable proliferation and perhaps is activated when NSCs undergo 
differentiation.  
(iv) NFI genes. NFIA, NFIB and NFIX are highly expressed in LeX+ve 
CD93+ve Phbrt+ve cells suggesting their importance in NSCs. These genes 
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belong to the NFI gene family, which consists of four members including 
NFIC. The NFI gene family is highly conserved in vertebrates such as chicken 
[305, 306], Zebrafish [307], Xenopus [308, 309] and humans [310, 311] and 
encodes transcription factors which control the expression of many genes 
involved in organ development [312]. NFIA, NFIB and NFIX are all expressed 
in the VZ and SVZ during embryonic development [313, 314]. Knockout mice 
for all three genes have been generated and their brain phenotypes 
characterized. NFIA, NFIB and NFIX mutants were observed to have enlarged 
lateral ventricles in the brain [313, 315-317]. NFIA and NFIB mutants show 
agenesis of corpus callosum [315-317] and NFIX mutants show defects in 
cortical NP proliferation and migration [313]. NFIA, NFIB and NFIX have 
also been shown to be expressed throughout the developing hippocampus with 
high expression in the DG where NSCs are present [313, 318]. In the 
hippocampus, NFIA mutants have defects in glial morphology [317], NFIB 
mutants have incomplete development of the supragranular glial bundle [319] 
and NFIX mutants display delayed NP differentiation, depletion of NPs in the 
SGZ, a smaller DG and an enlarged CA1 region [313, 320]. While the brain 
phenotypes of NFI mutants have been described substantially, the role of NFI 
genes in NSC self-renewal, proliferation, migration and neurogenesis is still 
unclear. It could be possible that the NFI genes promote self-renewal of NSCs 
and ablation of these genes leads to depletion of NSCs. This in turn 
contributes to the enlarged lateral ventricles and defects in downstream NP 
proliferation and differentiation observed in the NFI mutants.  
(v) POU3F3. POU3F3, also known as Brn1, is a member of the class 
III POU family of transcription factors. POU3F3 is expressed in mature NPs 
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and migrating neurons in the developing neocortex and seems to function 
synergistically with POU3F2. Double disruption of POU3F3 and POU3F2 
resulted in decreased numbers of layer IV-II neurons and abnormal migration 
of neurons, indicating that both these factors are important for neuronal 
development and positioning [321, 322]. POU3F3 also functions 
synergistically with Sox10 and Sox11 during oligodendrogenesis [323]. While 
it is clear that POU3F3 is critical during neurogenesis and oligodendrogenesis, 
its function in NSCs is not known. High expression of POU3F3 in the 
developing VZ/SVZ region as shown by images from the Allen Brain Atlas 
supports that POU3F3 is important for NSC function. It could be possible that 
POU3F3 functions synergistically with other Sox proteins such as Sox2 to 
promote self-renewal and proliferation of NSCs. In addition, it has been 
shown that POU3F3 regulates expression of Nestin, an NSC marker, in P19 
NP cells by binding to the Nestin enhancer [324]. Perhaps POU3F3 also 
regulates Nestin expression in NSCs and contributes to NSC function. 
(vi) HMGA2. The only gene significantly expressed at a lower level in 
LeX+ve CD93+ve Phbrt+ve population compared to the unsorted population was 
HMGA2. This strongly suggests that expression of HMGA2 is specific to NPs 
rather than NSCs. However, HMGA2-deficient fetal and young adult mice 
have reduced NSC numbers and HMGA2 was found to be crucial for NSC 
self-renewal [39]. It could be possible that HMGA2 is important for NSC 
function at the fetal and adult stage but not at the embryonic stage. This is 
further supported by images from the Allen Brain Atlas which show that 




Overall, the mRNA profile of LeX+ve CD93+ve Phbrt+ve cells helps 
identify candidate genes and signalling pathways which could be important for 
NSC function. Studying the functions of these genes and signalling pathways 
would help us understand the key regulatory mechanisms that help maintain a 
cell as an NSC. 
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7 CONCLUSION AND FUTURE WORK 
In this thesis, I show that neurospheres consists of three major 
progenitor subclasses which follow a developmental timeline of early, 
intermediate and late. The neurosphere subclasses resemble the subclasses 
found in mouse brain suggesting neurospheres can be used to model CNS 
development. The level of Notch signalling and expression level of Bmi1, 
Hes5, Klf12 and Myc determine the developmental stage of a neurosphere cell. 
I then derive the mRNA profile of NFCs and show that early NPs are the cell 
population that forms neurospheres. I also derive the mRNA profiles for 
NSCs, bi/unipotent NPs and non-NFCs and demonstrate that NSCs in vitro are 
heterogeneous. Lastly, I identify candidate genes and signalling pathways 
which could play important roles in NSC biology. 
Future studies could address the following issues which pan out from 
the findings in this thesis: (i) Using neurospheres to model CNS development. 
The presence of early, intermediate and late NPs suggests that developmental 
timeline is being followed in vitro. Studying the mechanisms of how early 
NPs develop into late NPs in neurospheres and the interaction between the 
different progenitor subclasses could help us understand the intricacies of CNS 
development. (ii) Novel genes and signalling pathways important for NSCs. 
The mRNA profile of NSCs has identified the Hippo signalling pathway and 
genes such as Tead2 and NFIA whose functions in NSCs are unclear. 
Functional studies could be performed to understand the role of the Hippo 
signalling pathway and the candidate genes in NSC self-renewal, proliferation 
and differentiation both in vitro and in vivo. (iii) NSC heterogeneity. Single-
cell mRNA profiling suggest that NSCs in vitro are heterogeneous. The 
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reasons for the heterogeneity could be investigated. For instance, it could be 
possible that different NSCs are at different stages of the cell cycle or have 
varying propensity to differentiate into a specific cell type. This could help us 
understand the functional significance of NSC heterogeneity in regulating 
brain growth and development. (iv) Identification of specific NSC markers. 
The genes described in the mRNA profile of NSCs could be linked to, or 
themselves function as novel NSC markers. Surface proteins or transgenic 
systems which report the expression of intracellular proteins described in the 
NSC mRNA profile could be used to isolate a pure NSC population. 
Alternatively, this approach could derive a population further enriched for 
NSCs which in turn could be used to identify novel NSC markers. (v) Role of 
other protein classes in NSCs. Here, I investigated the expression level of a 
number of classes of proteins such as transcription factors, surface proteins 
and epigenetic factors using single-cell mRNA profiling. The same tool could 
be used to profile the expression of other classes of proteins in NSCs. For 
instance, recent work has suggested that enzymes involved in lipid metabolism 
could play important roles in NSCs (Seong Wook et al., unpublished). The 
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